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Occurrence of Yersinia enterocolitica and Aeromonas 






The interest on the occurrence of Yersinia enterocolitica and Aeromonas 
hydrophila, their pathogenicity and antimicrobial resistance is increasing 
worldwide because both were linked to acute and chronic gastroenteritis, 
septicemia and wound infections. Though reports on the occurrence of both 
pathogens among human that are available from certain areas, no published 
data are available from Gaza strip. Moreover, there are no routine methods 
for the detection of Yersinia and Aeromonas in clinical or environmental 
samples. Hence this study investigated the occurrence of both Y. 
enterocolitica and A.  hydrophila in clinical and environmental samples. Of 
the 473 clinical and environmental samples, 28 (5.9%) were positive for Y. 
enterocolitica and 179 (38.1%) for A. hydrophila. With high incidence of Y. 
enterocolitica and A. hydrophila in sewage (19.1%) and water (46.9%) 
respectively. The overall incidence of Y. enterocolitica and A. hydrophila in 
clinical samples was 4.7% and 34.3% respectively, with high frequency of 
both pathogens in AL-Dorrah and AL-Nasser hospitals. Virulence of isolates 
was assessed and their antimicrobial resistance to 20 antimicrobial agents 
was evaluated. Both clinical and environmental isolates possessed virulence 
factors with higher frequency in clinical samples. Antibiotic susceptibility 
testing revealed that most of Y. enterocolitica isolates were sensitive to most 
antibiotics; on the other hand, most of A. hydrophila isolates showed multiple 
antibiotic resistances. The most effective antimicrobials on A. hydrophila 
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 تواجد  اليرسينيا انتيروآولتيكا و االيروموناس هيدروفيال في عينات سريرية و غذائية و






سببها و إلا ي ت راض الت دروفيال و االم اس هي ا و االيرومون ينيا انتيروآولتيك ن اليرس ل م ود آ ام بوج هتم
توى العالمي نظرًا الرتباط آال الكائنين بمجموعة من  على المس  مستمر مقاومتها للمضادات الحيوية في تزايد 
و بالرغم من وجود تقارير . خمج الدم و التهابات الجروح, األمراض مثل االتهابات المعوية الحادة و المزمنة 
شورة عن قطاع غزة  ات من الم اليوجد أي بيان  .عن وجود هذين الكائنين في البشر في اماآن معينة من الع
ة و وجد طرق محددة للكشف عن اليرسينيا و االيرومون ت فضال عن ذلك ال  سريرية والبيئي ات ال  اس في العين
لٍ  فقد بحثت لهذا السبب  دروفيال في  هذه الدراسة تواجد آ ا و االيروموناس هي   من اليرسينيا انتيروآولتيك
وي البكتيريا  المعزولة اجري لها اختبار الفوعة و مقاومتها لعشرين مضا . هذه العينات  سبة . د حي و آانت ن
الي  ة آالت سريرية و البيئي ات ال ن العين ة م ا المعزول ا و %) 5.9 (28: البكتيري ينيا انتيروآولتيك  179يرس
سبة %) 38.1( ى ن ت أعل دروفيال و آان اس هي دايرومون ينيا تواج ا  لليرس اس   وانتيروآولتيك االيرومون
ي .على التوالي ) %46.9 (عينات الماء و%) 19.1( في عينات المجاري   الهيدروفيال  و آان المجموع الكل
سريرية لكٍل من  ات ال دروفيال من العين  %)34.3( و %)3.7( هو اليرسينيا انتيروآولتيكا و االيروموناس هي
والي  ى آانت و , على الت سبة  أعل لٍ  ن ائنين  من لك شفى النصر  الك درة ومست شفى ال ل من ا. في مست وت آ حت
سريرية  لهذه العوامل  عوامل الفوعة مع زيادة واضحة العزالت البيئية و السريرية على  د  و, في العزالت ال  ق
ة أظهرت نتائج حساسية المضادات بأن اليرسينيا انتيروآولتيكا حساسة لمعظم المضادات   المفحوصة  الحيوي
ددة  ة المتع ن المقاوم ة م سبة عالي دروفيال ن اس هي زالت االيرومون رت ع ا أظه ام و . بينم ان االزتريون و آ
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Yersinia enterocolitica and Aeromonas hydrophila are Gram-negative, 
facultative anaerobic bacteria that can be isolated from many sources, such 
as food, drinking water, sewage, environmental water and human clinical 
samples with a world-wide distribution. These bacteria can develop in 
refrigeration temperatures and are responsible for food and water-borne 
diseases, that can cause a range of human diseases that vary in severity 
from a self-limiting gastroenteritis to potentially fatal septicemia [1,2]. 
 
The genus Yersinia comprises an important group of bacterial pathogens, 
with Yersinia enterocolitica, Y. pseudotuberculosis, and Y. pestis 
representing the species of interest. Y. pestis is the etiologic agent of plague, 
whereas Y. enterocolitica and Y. pseudotuberculosis are enteropathogens 
which cause a variety of intestinal and extraintestinal clinical symptoms of 
varying severity ranging from mild gastroenterititis to mesenteric 
lymphadenitis, which mimics appendicitis and septicemia [3]. Y. 
enterocolitica is the most common agent of this genus that are pathogenic for 
both humans and animals and have a nearly worldwide distribution. Human 
clinical infections with this species ensue after ingestion of the 
microorganisms in contaminated food or water or by direct inoculation 
through blood transfusion [4]. 
 
Both pathogenic and nonpathogenic strains are frequently isolated from 
various animals (birds, mammals, and reptiles), foods (milk, meat, eggs, 
vegetables) contaminated with feces of infected animals or secondarily 
during the technologic process, as well as from the environment (water and 
soil). Rodents (mice and rats), hares, rabbits, and birds serve as reservoirs 
for Y. pseudotuberculosis [5], with swine serving as a major reservoir for 
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human pathogenic strains of Y. enterocolitica, and the highest isolation rates 
have been reported during the cold season in temperate climates [6]. 
 
Clinical illness is characterized by diarrhea and/or vomiting, fever and acute 
abdominal pain caused by mesenteric lymphadenitis, and it is often clinically 
indistinguishable from acute appendicitis. Sometimes post-infections, more 
specifically extra-intestinal sequelae, such as reactive arthritis, erythema 
nodosum, erythema multiforme, scarlatiniform exanthemata and septicemic 
types deserve particular clinical attention [7]. 
 
The major mechanism of virulence of Yersinia species, is invasiveness [8], 
which is mediated by genes inv, ail, and yadA, the first two of these are 
chromosomal and the last, plasmidial. These genes are responsible for the 
production of the proteins Inv (invasin), Ail (attachment invasion locus) and 
YadA (Yersinia adhesion) [9]. The virulence plasmid pYV (40-48 KDa) 
expresses different phenotypic characteristics such as autoagglutination at 
37oC, calcium dependence at 37oC, and Congo red uptake. A set of three 
tests has been proposed to separate pathogenic from non-pathogenic 
Yersinia strains; pyrazinamidase activity, esculin hydrolysis and salicin 
fermentation [10]. Studies on the behavior of two species of Yersinia have 
demonstrated that the microorganisms are susceptible to large number of 
antibiotics and chemotherapeutic agent [11].  
 
The Aeromonas genus has been placed in its own family, the 
Aeromonadaceae. The aeromonads share many biochemical characteristics 
with members of the Enterobacteriaceae, from which they are primarily 
differentiated by being oxidase-positive. The genus includes at least 13 
species, among which are the motile, mesophilic A. hydrophila, A. caviae, A. 
sobria, A. veronii, and A. schubertii, and the non-motile, psychrophilic A. 
salmonicida [12]. Seasonal variations in isolation of Aeromonas from stools 
have also been reported, with highest recovery during the warmer months. 
The mesophilic species have been associated with a wide range of infections 
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in humans, that have been isolated from freshwater, salt water, ground 
waters, drinking water (chlorinated and unchlorinated drinking water) [13], 
and have been frequently isolated from various food products such as fish 
and shellfish, raw meat, vegetables and raw milk, and from patients with 
diarrhea [14]. 
 
Among Aeromonas species, Aeromonas hydrophila is most commonly 
associated with human infections, leading to intestinal and non-intestinal 
diseases. Furthermore, increased resistance of this organism to antibiotics 
and chlorination in water presents a significant threat to public health. As a 
result, the Environmental Protection Agency (EPA) began the monitoring of 
United States water supplies for this organism in 2002 [15]. These pathogens 
have been associated with several categories of human infections, such as 
gastroenteritis (“summer diarrhea”), peritonitis, endocarditis, septicemia, 
septic arthritis, acute renal failure, and pneumonia [16]. Epidemiological 
studies implicated Aeromonas species in causing water and food-borne 
outbreaks and traveler's diarrhea [17].  
 
A. hydrophila produce an array of virulence factors, and the pathogenesis of 
Aeromonas infections is therefore complex and multifactorial. These factors 
include O antigens, capsules, the S layer, flagella, exotoxins such as 
hemolysins, and enterotoxin, and a repertoire of exoenzymes which digests 
cellular components. These virulence determinants are involved sequentially 
in enabling the bacteria to colonize, gain, entry, establish, replicate, and 
cause damage in host tissues and to evade the host defense system and 
spread, eventually killing the host [18]. Phenotypic characteristics of 
Aeromonas spp. have been used to differentiate between environmental 
strains and those strains causing gastroenteritis; including the lysine 
decarboxylase, Voges-Proskauer and autoagglutination positivity tests, 
congo red and crystal violet uptake and the production of a cell-free 
hemolysin and cytotoxin [19]. 
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Y. enterocolitica and A. hydrophila are important human pathogens that are 
increasingly recognized by researchers as a cause of various clinical 
syndromes [20,21]. The presence of Y. enterocolitica and A. hydrophila in 
food products is of a special concern since those organisms are capable of 
growth at refrigerator temperatures. The presence of these pathogens in 
clinical, food and environments represents possible hazard [5,14].  In several 
countries, Y. enterocolitica has eclipsed Shigella species and approaches 
Salmonella species and Campylobacter species as the cause of acute 
bacterial gastroenteritis [5]. 
 
There is no published or unpublished data concerning these pathogens in 
Gaza strip and there are no routine methods for the detection of these 
pathogens in any of the concerned authorities (Ministry of health, 





The objectives of this wok are to investigate the presence of Y. enterocolitica 
and A. hydrophila in clinical, food and environmental samples; to examine the 
distribution of these isolates in the different areas in Gaza strip; and to 
evaluate the methods for the recovery of Y. enterocolitica and A. hydrophila 
from clinical, food and environmental samples. The specific aims are as 
follows: 
  
1- To determine the occurrence of Y. enterocolitica and A. hydrophila in 
clinical, food and environmental samples. 
2- To evaluate the methods used to detect Yersinia and Aeromonas 
pathogens in clinical, food and environmental samples. 
3- To compare the occurrence of both bacteria in different sample types and 
sources. 
4- To examine the virulence factors of the isolates. 




Y. enterocolitica and A. hydrophila are considered as emerging water and 
food-borne pathogens because it was shown that Yersinia and some 
Aeromonas food isolates can produce different virulence factors, not only at 
optimal growth temperature, but also at refrigeration temperatures, increasing 
concern about water and food-borne transmission.  
 
These microorganisms are recognized as an important agent of diarrheal 
diseases associated with a wide spectrum of clinical and immunological 
manifestations. As a result of an episode of food poisoning in the United 
States caused by ingestion of Yersinia contaminated chocolate milk and the 
presence of A. hydrophila in fish and seafoods lead the U.S. Food and Drug 
Administration (FDA) to designate them as a “new” foodborne. At the 
beginning of the program it was known that the Yersinia and Aeromonas 
species associated with food poisoning were among the few enteric 
pathogens capable of growth at refrigeration temperature (4°C). Also 
resistance of Aeromonas spp. to water chlorination and to multiple antibiotics 
has resulted in listing the organism on the “Contaminant Candidate List” by 
the EPA. 
 
This research attempted to detect these pathogens in clinical, food and 
environmental samples in different areas of Gaza strip and determine 
sources of Y. enterocolitica and A. hydrophila. Data generated from this work 
would be the first to highlight these important pathogens in Gaza strip and it 
is expected that the results would provide essential background for policy 




LITERATURE REVIEW  
 
This chapter is divided into two major parts; the first part is concerned with Y. 
enterocolitica and the second part is dedicated to A. hydrophila. Each part is 
discussing and reviewing details of the organism (Historical background and 
taxonomy, ecology and host range, pathogenesis, factors affecting growth, 
isolation, identification, conformation of pathogenicity, prevalence, infection 
and epidemiology of the organism). 
 
2.1 Yersinia enterocolitica   
 
2.1.1 Historical background and taxonomy 
 
In 1944, Van Loghem proposed that a new genus, designated Yersinia, be 
separated from the genus Pasteurella. This proposition became effective in 
1974. The first species identified in this genus by Malassez and Vingal in 
1883 was Yersinia pseudotuberculosis. The second species, Yersinia 
enterocolitica, was identified in 1939 by Schleifstein and Coleman. This 
species was found to be heterogeneous and to contain several related 
species (‘’Y. enterocolitica-like’’) that were subsequently designated Y. 
intermedia, Y. frederiksenii, Y. kristensenii, Y. aldovae, and Y. rhodei. More 
recently, Y. mollareii and Y. bercovieri were also separated from Y. 
enterocolitica. Finally, the species Y. ruckeri was included in the genus 
Yersinia but its classification in this genus is controversial [22]. Wild-type Y. 
pestis and Y. pseudotuberculosis exhibit nearly identical chromosomal DNA 
relatedness [23]. 
 
The genus Yersinia presently consists of 11 species, three of which can 
cause disease in humans and animals; Y. enterocolitica, Y. 
pseudotuberculosis and Y. pestis [24]. They are invasive pathogenic 
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bacteria, which have a common capacity to resist non-specific immune 
response and are lymphotrophic. These three pathogenic species differ 
considerably in invasiveness; while Y. enterocolitica and Y. 
pseudotuberculosis can cross the gastro-intestinal mucosa to infect 
underlying tissue, Y. pestis is injected into the body by an insect bite, and 
thus, does not have to penetrate any body surface on its own [25]. 
 
Y. enterocolitica are included in the genus Yersinia, which are classified into 
the family Enterobacteriaceae, a group of gram-negative, oxidase-negative 
and facultatively anaerobic bacteria. All bacteria belonging to the genus 
Yersinia are catalase-positive, non-spore-forming rods or coccobacilli of 0.5-
0.8 x 1-3 µm in size. Strains belonging to Y. enterocolitica are urease-
positive and can be differentiated from Y. pseudotuberculosis with a positive 
result for fermentation of sucrose, and negative reactions for rhamnose and 
melibiose fermentation. Y. enterocolitica Y. pseudotuberculosis are more 
active biochemically at 25°C than at 37°C, giving, for example, a positive 
Voges-Proskauer test only at the lower temperature. Most of the strains are 
motile at 25°C but non-motile at 37°C [25].  
 
Y. enterocolitica and bacteria that resemble it are ubiquitous, being isolated 
frequently from soil, water, animals, and a variety of foods [5]. They comprise 
a biochemically heterogeneous group that can grow at refrigeration 
temperatures [26]. Based on their biochemical heterogeneity and DNA 
relatedness, members of this group were separated into four species: Y. 
enterocolitica, Y. intermedia, Y. frederiksenii, and Y. kristensenii. Y. 
enterocolitica strains and related species can be separated serologically into 
groups based on their heat-stable somatic antigens [27].  
 
Y. enterocolitica is divided into 18 serogroups. Presently, pathogenic strains 
belonging to serogroups O:1, 2a, 3; O:2a, 3; O:3; O:8; O:9; O:4,32; O:5,27; 
O:12,25; O:13a,13b; O:19; O:20; and O:21 have been identified. Therefore, 
pathogenic strains can belong to diverse serogroups. Serogroups that 
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predominate in human illness are O:3, O:8, O:9, and O:5,27 [27]. These 
bioserotypes have been shown to have different geographical distributions. 
Strains that are largely responsible for human yersiniosis in Europe, Japan, 
Canada and USA belong to bioserotype 4/O:3. Bioserotype 4/O:3 has been 
recovered in Japan and China, bioserotype 2/O:9 mostly in Europe, and 
bioserotype 2/O:5,27 is more widely distributed. Strains of bioserotype 
1B/O:8 are mostly limited to the USA, but have sporadically appeared in 
France, Italy and Japan as well [28]. Biotype 1A is considered to be non-
pathogenic; however, isolates of this biotype have constituted a sizeable 
fraction of isolates from patients with gastroenteritis [29]. 
 
2.1.2 Ecology and host range  
 
Y. enterocolitica is robust organisms capable of long-term survival in natural 
environments due, in part, to their minimal nutritional requirements and ability 
to remain metabolically active at extremes of temperature. This capacity to 
remain viable in nature for extended periods of time as a fecal contaminant 
is, of course, especially advantageous to these organisms, which are 
transmitted to hosts via the oral route [30]. Y. enterocolitica is widely 
distributed in nature in aquatic and animal reservoirs, with swine serving as a 




Human clinical infections with Y. enterocolitica ensue after ingestion of the 
microorganisms in contaminated food [32], or water [33] or by direct 
inoculation through blood transfusion [34]. In the gastrointestinal tract, Y. 
enterocolitica and Y. pseudotuberculosis can cause acute enteritis 
(especially in children), enterocolitis, mesenteric lymphadenitis, and terminal 




2.1.3.1 Plasmid-encoded virulence factors 
 
All fully virulent Y. enterocolitica strains carry an approximately 70-kb 
plasmid, termed pYV (plasmid for Yersinia virulence), which is required for 
full expression of virulence. Virulence plasmids of pathogenic Yersinia are 
closely related to each other, sharing functional similarities and a high degree 
of DNA homology. The presence of pYV enables Yersinia species to survive 
and multiply in lymphoid tissues of their host [36]. This pYV codes for an 
outer membrane protein YadA (Yersinia adhesin A), a set of secreted 
proteins called Yops (Yersinia outer membrane protein), and their secretion 
apparatus called Ysc (Yop secretion) [37].  
 
The YadA protein is multifunctional and promotes binding to epithelial cells. 
The gene yadA codes for the major outer membrane protein YadA, which 
forms a fibrillar matrix on the surface of Y. enterocolitica and is only 
expressed at 37°C. YadA plays a protective role in Y. enterocolitica, with 
several different functions such as, serum resistance, surface hydrophobicity 
autoagglutination, adhesion to epithelial cells, expression of fibrils on the 
surface, haemagglutination, binding to intestinal brush border membranes 
and resistance to killing by polymorphonuclear leukocytes [38]. One major 
role of YadA is to protect Y. enterocolitica against killing by 
polymorphonuclear leukocytes. Although the mechanism is unknown, YadA 
has been suggested to act by binding to eukaryotic cells, and in doing so, 
allow delivery of the Yops, thus preventing phagocytosis [39].  
 
The yop genes located on the pYV code for at least 14 Yops, which were 
originally described as Yersinia outer membrane proteins because they were 
detected in the outer membrane fraction of bacterial extracts. With the type III 
secretion system (Ysc), extracellularly located Yersinia that are in close 
contact with the eukaryotic cell deliver toxic bacterial proteins (Yops) into the 
cytosol of the target cell [40].  Some of the Yops form pores in the eukaryotic 
target cell membrane, while the other Yops are effector proteins that are 
 10
delivered through these pores into the cytosol of the target cell. At least six 
different Yop effectors are injected by the Ysc secretion translocation 
apparatus [41].  
 
Genes specifying the type III machinery (ysc) are also located on the pYV. 
The yop and ysc genes are temperature- and calcium-regulated, being 
expressed maximally at 37°C in response to the presence of a low calcium 
concentration [42]. All Yersinia strains carrying the virulence plasmid exhibit 
a phenotype known as low-calcium response because it manifests only when 
pYV-bearing strains are grown at 37°C in media containing a low 
concentration of Ca2+ [43].  
 
2.1.3.2 Chromosome-encoded virulence factors 
 
Chromosome-encoded factors are also needed for pathogenicity. Virulence 
functions have demonstrated to be transferable with the virulence plasmid 
only to the plasmid-cured strains derived from virulent parenteral strains [44]. 
Adherence to and invasion of epithelial layers require at least two 
chromosomal genes, inv (invasion) and ail (attachment invasion locus) [45].  
 
A. The invasion (inv) codes for Inv, an outer membrane protein found on the 
surface of Yersinia, which appears to play a vital role in promoting entry into 
epithelial cells of the ileum during the initial stage of infection, that is 
responsible for binding to β_1-integrins on the apical surface of M cells and 
initiating uptake of the organism [46]. Migration through these cells leads to 
the accumulation of bacteria in the underlying lymphoid tissue (Peyer’s 
patches) and spread to the mesenteric lymph nodes [47]. This gene is found 
in all Yersinia spp., however, non-pathogenic strains lack functional inv 
homologous sequences [48]. Expression of inv in Y. enterocolitica responds 
to both temperature and pH. inv expression is higher at 26°C than 37°C 
during in vitro growth, with maximal expression occurring during late 
logarithmic to early stationary phase; however, expression of inv at 37°C can 
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be restored to levels comparable to 26°C by adjusting the pH of the medium 
to 5.5 [49].  
 
B. The attachment invasion locus (ail)  codes for the surface protein Ail, 
which is produced at 37°C. In contrast to the inv, the ail was shown to be 
restricted to strains of serotypes associated with disease [50]. 
 
C. The heat-stable enterotoxin (Yst) of Y. enterocolitica is chromosomally 
mediated [51]. The role of enterotoxin in the pathogenesis of Y. enterocolitica 
infection is unclear. Non-pathogenic strains of Y. enterocolitica and strains of 
related species have been found to produce Yst using the infant mouse 
model, and the yst gene has been detected in strains of biotype 1A, Y. 
kristensenii and Y. intermedia [52]. Absence of enterotoxin production in vitro 
at temperatures exceeding 30°C suggests that this toxin is not produced in 
the intestinal lumen. However, it has been demonstrated with isogenic Yst+ 
and Yst- strains in young rabbits that, at least in this model, Yst was 
responsible for diarrhea [53,54]. 
 
D. Lipopolysaccharide (LPS) is a major surface component of the outer 
membrane of gram-negative bacteria. In Yersinia, the genes directing the 
biosynthesis of LPS are chromosomally located. LPS is a complex molecule 
composed of three main parts: lipid A, oligosaccharide core and O-side chain 
(O-antigen). The lipid A part is believed to be responsible for endotoxin 
activity and to play a central role in sepsis and septic shock due to gram-
negative bacteria [55]. LPS of Y. enterocolitica O:8 has a unique structure in 
which the outer core forms a branch. Serotypes of Y. enterocolitica are 
mainly determined by the variability of O-antigen. While the O-antigen is 
required for full virulence, its role has yet to be clarified, and absence of O-
antigen affects the expression of other virulence factors. A total absence of O 
antigen in Y. enterocolitica has been shown to reduce virulence in the 
infected mouse model [56]. 
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E. Urease is produced by all clinical isolates of Y. enterocolitica and is 
encoded by the urease gene complex (ure) on the chromosome. Bacterial 
survival depends on the ability to tolerate changes in the environment such 
as temperature, pH, osmolarity, and nutrient availability [57]. Bacteria are 
able to coordinate appropriate physiological responses to non-life-threatening 
or gradual environmental changes. Y. enterocolitica is a good example of 
how survival depends upon the ability of the bacteria to adapt to 
environmental changes.  While most environmental changes experienced by 
Y. enterocolitica going from the free-living environment to the host 
environment allow for a progressive coordinated bacterial response, some 
conditions, such as changes in pH, occur rapidly and are potentially lethal, 
requiring the bacteria to maintain presumptive mechanisms for survival [30].  
 
However, more recent studies have implicated urease as a factor that is 
necessary for survival and pathogenesis of some bacteria [58]. More 
recently, urease activity was shown to affect survival of Y. enterocolitica O:9 
under acidic conditions both in vitro and in vivo. For Y. enterocolitica O:8 and 
Morganella morganii, the authers describe how this enzyme contributes to 
survival. In addition, the contribution of urease to acid tolerance was 
determined for other gram-negative bacteria that survive both free-living and 
in a susceptible host. The decrease in virulence after intragastric inoculation 
of Y. enterocolitica O:3 urease-negative mutant indicates that the main role of 
urease is during the initial stage of the bacterial infection, when the bacteria 
reach the stomach [59]. 
 
F. Iron is an essential micronutrient for almost all bacteria, including Y. 
enterocolitica. A variety of alternative pathways have been elucidated for the 
uptake and utilization of iron by Yersinia. To capture iron, highly pathogenic 
strains of Y. enterocolitica biotype IB posses a genomic high-pathogenic 
islands (HPI) [60]. This 35 to 45-kb island carries a siderophore- mediated 
iron uptake system named the yersiniabactin (Ybt) locus, which is required 
for full virulence expression in Yersinia. The yersiniabactin biosynthesis and 
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transport genes are clustered within high-pathogenic islands. The less 
virulent strains of other bioserotypes of Y. enterocolitica, including 
bioserotype 4/O:3, are able to bind and internalize a number of exogenously 
produced siderophores such as ferrioxamine and ferrichrome [61]. Several 
studies reported Yersinia species in clinical states of iron overload, such as 
hemochromatosis, thalassemia and in children following accidental iron 
overdose [62]. 
 
2.1.4 Factors affecting growth 
 
Y. enterocolitica, as a psychrotrophic bacterium, has the ability to replicate at 
temperatures between 0 and 44°C [26]. The doubling time at the optimum 
growth temperature (approximately 28 to 30°C) is around 34 min. Although 
Y. enterocolitica can grow at temperatures as low as 0°C, the organism 
grows much more slowly as temperatures drop below 5°C [63]. Goverde et 
al., demonstrated that pYV positive strains grow slower than pYV-negative 
ones at 30-35°C and 1-10°C. Yersinia withstands freezing and can survive in 
frozen foods for extended periods even after repeated freezing and thawing, 
but it is susceptible to heat and is destroyed by pasteurization at 71.8°C for 
18 seconds [64]. 
 
Y. enterocolitica is able to grow over a pH range from approximately 4 to 10, 
with an optimum pH of around 7.6. Yersinia can survive alkaline conditions 
better than other gram-negative bacteria [65]. However, since few foods 
have an alkaline pH, this high pH tolerance is relatively unimportant. The 
bacterium’s tolerance of acidic conditions, on the other hand, is of great 
significance. Survival of the high acidity of some foods and the passage 
through the stomach suggests that Y. enterocolitica species are relatively 
acid-resistant. Although the mechanism of acid tolerance is unknown, it may 
be due to the activity of urease, which catabolizes urea to release ammonia, 
which in turn elevates the cytoplasmic pH [57].  
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Tolerance of Yersinia to acid depends on the acidulent used, the 
environmental temperature, the composition of the medium, and the growth 
phase of the bacteria. Acetic acid has been shown to be a more effective 
inhibitor than either lactic or citric acid [66].  
 
Y. enterocolitica is a facultatively anaerobic bacterium that can grow in 
anaerobic conditions. This bacterium can also grow well in modified 
atmospheres at 8°C, but with higher levels of CO2, the length of lag phase 
will increase and growth will be slower [67]. Y. enterocolitica has been shown 
to grow well on meat when packaged in vacuum or in modified atmosphere 
and stored at 5°C, even in the presence of high background flora [68].  
 
Several studies demonstrated that Y. enterocolitica can grow well on both 
decontaminated and untreated pork when packaged in vacuum and stored at 
10°C. However, the growth of serotype O:3 in raw minced meat has been 
found to be inhibited by natural microflora of the meat in some studies [69]. 
 
Y. enterocolitica can tolerate salt (NaCl) at concentrations of up to 5% [70]. 
The inhibition caused by NaCl is strongly dependent on storage temperature.  
Inactivation of Y. enterocolitica by chlorine (0.6 to 20 ppm) was investigated 
in distilled water and in Trypticase soy broth (TSB, 0.015%) at different 
temperatures (4, 20, and 40oC). In distilled water, chlorine inactivation of Y. 
enterocolitica was enhanced by increasing the temperature from 4 to 20oC. 
Y. enterocolitica can tolerate both sodium nitrate and nitrite of up to 20 mg/ml 
for 48 h in vitro. However, a nitrite concentration of only 80 mg/kg has been 







2.1.5 Isolation and identification of pathogenic Yersinia enterocolitica 
from clinical, foods and environmental samples 
 
2.1.5.1 Isolation and enumeration 
 
The source of Y. enterocolitica may markedly affect the methods of isolation. 
To find pathogenic isolates from food and environmental sources is generally 
more difficult than to find them from stools of infected individuals. During 
acute gastroenteritis or with organ abscesses, pathogenic Y. enterocolitica 
are often the dominant bacteria and can easily be isolated by direct plating 
on conventional enteric media [72]. Because of the high number of 
background flora and the low number of pathogenic strains of Yersinia in 
food and environmental samples, direct isolation even on selective media is 
seldom successful. To increase the number of Yersinia strains in these 
samples, enrichment in liquid media prior to isolation on solid media is 
required [73].  
 
Recovery of pathogenic Y. enterocolitica is contingent upon a number of 
factors including: the level of background flora on the product; the amount of 
background flora coming through enrichment and plating; the level of 
pathogenic Y. enterocolitica on the sample; the numbers of non-pathogenic 
Y. enterocolitica and non-pathogenic Yersinia spp. present on the product; 
and loss of virulence factors during enrichment and plating [74]. Furthermore, 
a recovery method which gives good recovery of one serotype of pathogenic 
Y. enterocolitica may not be suited to other serotypes. In order to recover any 
of the important pathogenic serotypes of Y. enterocolitica which might be 
present, multiple enrichment broths and plating media are usually 
recommended for the recovery of the organism from naturally-contaminated 
foods. Several different methods are available for isolation of Y. enterocolitica 




2.1.5.1.1 Cold enrichment 
 
The psychrotrophic nature of Y. enterocolitica is unusual among enteric 
bacteria, and consequently, enrichment in different solutions at 4°C for 
prolonged periods has been used for isolation of Yersinia spp. [75]. Cold 
enrichment in phosphate buffered solution (PBS) or in phosphate buffered 
saline with sorbitol and bile salts (PSB) has been widely used for clinical, 
food, and environmental samples [76]. In addition, nutritionally richer media, 
such as TSB, have been reported to yield better results, particularly when 
food and environmental samples are studied [74]. One major disadvantage 
encountered with cold enrichment is the long incubation period, typically 21 
days, which is unacceptable for quality assurance of foods. Doyle and 
Hugdahl have shown that incubation in PBS for 1-3 days at 25°C is as 
efficient as enrichment at 4°C for some weeks [77]. Another problem with 
cold enrichment is the presence of other psychrotrophic bacteria in foods, 
which also multiply during the enrichment. By treating cold enrichments with 
potassium hydroxide (KOH), the background flora can be reduced, making 
selection of Yersinia colonies easier [78]. This alkali treatment was 
developed by Aulisio et al., after they observed that Yersinia spp. are more 
tolerant of alkali solutions than many other gram-negative bacteria [65]. 
 
2.5.1.1.2 Selective enrichment 
 
Several selective media for isolation of Y. enterocolitica at higher 
temperatures have been developed [79], with different antimicrobial agents 
being used as selective supplements in these media. Wauters formulated a 
modified Rappaport broth (MRB) containing magnesium chloride, malachite 
green and carbenicillin, in which the sample was incubated at 25°C for 2-4 
days [80]. Later, Wauters et al., developed an enrichment broth derived from 
the modified Rappaport base, supplemented with irgasan, ticarcillin and 
potassium chlorate (ITC) [81].  
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Schiemann developed a bile oxalate sorbose (BOS) medium for the isolation 
of Y. enterocolitica, particularly for strains belonging to bioserotype 1B/O:8 
[82,83]. Pre-enrichment in low-selectivity medium prior to selective 
enrichment in MRB or BOS has also been used for isolation of Y. 
enterocolitica from foods [75]. 
 
2.5.1.1.3 Selective agar plates 
 
Several different selective agar plating media have been used for isolation of 
Y. enterocolitica. Initially, plating media, such as MacConkey (MCA) agar, 
deoxycholate citrate (DC) agar and Salmonella-Shigella (SS) agar, 
developed for other enteropathogens were used. On these media, Y. 
enterocolitica and Y. pseudotuberculosis strains grow well but slowly and are 
easily overgrown by other enteric bacteria because of the low selectivity. Of 
the traditional enteric media, the most widely used is MCA agar [82,83].  
 
Both modifying existing enteric media and development of entirely new media 
have achieved improvements in selectivity. SS agar was made more 
selective for Y. enterocolitica by addition of sodium deoxycholate and CaCl2. 
Used in combination with ITC enrichment, recovery of strains of bioserotype 
4/O:3 is good. This agar is widely used because of its high selectivity and 
commercial availability (ISO1994). However, differentiation of Yersinia from 
competing organisms, such as Morganella, Proteus, Serratia and 
Aeromonas, can be difficult. Cefsulodin irgasan novobiocin (CIN) agar is one 
of the media developed for isolation of Y. enterocolitica and Y. 
pseudotuberculosis [84].  
 
In several comparative studies, CIN agar was found to be the most selective 
plating medium for Yersinia spp. [85]. Organisms capable of fermenting 
mannitol, like Yersinia, produce red “bull's eye” colonies on CIN agar. Only 
Citrobacter freundii, Enterobacter agglomerans and species of Aeromonas 
and Klebsiella produce similar colony morphology [86]. Other selective agar, 
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virulent Yersinia enterocolitica (VYE) [5], hase been developed for isolation 
of Y. enterocolitica strains, but CIN agar is the most generally accepted 
because of its high selectivity and the high confirmation rate of presumptive 
isolattion. Moreover, the commercial availability of this medium makes it 




Johnson determined the minimum number of biochemical tests required for 
identifying Yersinia amongst bacteria growing and presenting similar colony 
morphology on CIN agar; two tests, Kligler iron and Christensen’s urea tests, 
were sufficient. Y. enterocolitica can be identified with biochemical tests such 
as fermentation of sucrose, rhamnose and melibiose [74]. 
 
 Commercial rapid identification tests provide suitable alternatives to the 
conventional tube tests. The Analytical Profile Index (API 20E) system, 
widely used for identification of presumptive Yersinia isolates, has been 
shown to be accurate in identifying of Y. enterocolitica. This kit system has a 
positive identification rate of 93% for Y. enterocolitica incubated at 28°C 
instead of 37°C. In the study by Sharma et al., identification of Y. 
enterocolitica biotypes 3, 4 and 5 was excellent, with a positive predictive 
value of 99% when the strips were incubated at 28°C for 18-24 h [87].  
 
2.1.6 Confirmation of pathogenicity 
 
Y. enterocolitica is a ubiquitous microorganism and, although the majority of 
isolates recovered from non-human sources are non-pathogenic, thus having 






2.1.6.1 Animal tests 
 
The pathogenicity of Y. enterocolitica can be studied by animal tests such as 
the guinea pig conjunctivitis model (Sereny test) [88], suckling mouse assay, 
mouse intraperitoneal challenge, and mouse diarrhea and splenic infection 
following oral challenge [89,90]. However, because animal testing tends to 
be costly and is subject to increasing public opposition, it has largely been 
replaced by in vitro tests. 
 
2.6.1.2 Phenotypic tests 
 
A number of phenotypic characteristics associated with the virulence plasmid 
have been described [91]. Calcium dependence, measured by growth 
restriction on magnesium oxalate agar [92], autoagglutination at 35-37°C 
[93], uptake of Congo red and crystal violet [94] are the most popular indirect 
markers for identifying pathogenic strains of Y. enterocolitica. The 
pyrazinamidase (PYZ) test and the tissue culture invasiveness assay are 
proven indicators of potentially pathogenic isolates [10]. However, both of 
these tests measures functions that are chromosomally mediated, and thus, 
cannot replace pathogenicity tests, since they are only correlated with the 
ability of the strain to harbor the plasmid, and not to the presence of the 
plasmid itself. No single phenotypic virulence-associated characteristic has 
been shown to be a reliable indicator of pathogenicity [95]. 
 
2.1.6.3 Genotypic tests 
 
Several colony hybridization, amplified fragment length polymorphism (AFLP) 
and polymerase chain reaction (PCR) assays have been designed to verify 
the pathogenicity of Y. enterocolitica isolates specifically and rapidly [96-98]. 
The methods are based on specific segments of the virulence plasmid or the 
chromosomal DNA that have known virulence functions.  
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2.1.7 Prevalence of Yersinia enterocolitica 
 
2.1.7.1 In animals 
 
Animals, especially domestic animals, have been suspected as transmitters 
of Y. enterocolitica to humans. Y. enterocolitica infection in animals is not 
notifiable, and reports on its prevalence are for the most part results from 
research projects obtained from institutions or authorities in the member 
countries. Various studies have investigated wild and farm animals for the 
presence of pathogenic strains of Y. enterocolitica, and only a few have been 
recovered [99]. Shayegani et al., examined fecal specimens from 1,426 
animals including mammals, birds, reptiles, fish and invertebrates throughout 
New York State. Eleven human pathogenic strains were isolated, including 
bioserotype 1B/O:8 , 4/O:3 and O:5,27 [100]. In various studies examining 
healthy domestic animals and animals with acute enteritis, including cattle, 
sheep, goats, deer, calves, broilers, hens, turkeys and ducks, only a few 
pathogenic isolates have been recovered, and they differed from those 
usually associated with human infections [101,102].  
 
Pet animals, such as cats and dogs, have been suspected of being 
reservoirs for human infections with Y. enterocolitica, because of their close 
contact with humans. Dogs and cats occasionally harbor Y. enterocolitica 
4/O:3 [103,104]. Fredriksson-Ahomaa, Korte and Korkeala showed that 
raw pork was an important source of yersiniosis in dogs and cats. The 
infected dogs showed no clinical signs of infection. The duration of fecal 
shedding by the dogs varied between 7 and 23 days. These findings suggest 
that dogs can act as a potential source of the infection to humans [6]. 
 
Pigs are healthy carriers of Y. enterocolitica 4/O:3 and are the only animal 
species from which the bacterium can be isolated frequently.  Based on 
results from several studies, it can be concluded that Y. enterocolitica 4/O:3 
is present in the pig population in many countries in the world. The 
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prevalence often varies herd-wise [6].  Korte et al., found that the 
prevalence in fattening pigs in Finland, investigated in five slaughterhouses, 
increased from 33% to 64% between 1995 and 1999 [105].  
 
2.1.7.2 In foods  
 
The primary route of human infection is most probably ingestion of food. 
Based on the information on domestic cases notified by clinicians for 2004 in 
Sweden, the Swedish Institute for Infectious Disease Control reported that 
75% of the yersiniosis cases were suspected to be food- or waterborne 
infections. However, pathogenic strains of Y. enterocolitica are difficult to be 
isolated from food. In several studies, high frequencies of nonpathogenic 
strains have been isolated from food, whereas pathogenic strains are only 
occasionally recovered [106]. In studies from different countries, various 
ready-to-eat products have been investigated including, fresh salad, whole 
and sliced vegetables, sandwiches, milk, dairy products, desserts and soft 
cheese [14]. Only a few pathogenic strains were isolated from these foods. 
 
Raw and pasteurized milk have been examined in several studies because 
outbreaks over a number of years in the United States were traced to milk. 
With the exception of a few isolates of O:5, 27, none of the strains isolated in 
these studies were identified as pathogenic [107]. Pork is likely to be an 
important vehicle of the infection to humans because pigs are the only 
animals consumed that frequently harbor the same bioserotype of Y. 
enterocolitica as is isolated from human yersiniosis cases. However, the 
problem is that only few pathogenic strains have been recovered from pork or 
pork products [5].  
 
From outbreaks and case-control studies, there are other indications that 
pork is involved in the transmission of the pathogen to humans. Two 
outbreaks have been traced to ingestion and/or handling of contaminated 
pork. In one outbreak, home prepared ‘pork cheese’ (a sausage variant) was 
identified as the source of the infection. Preparation of pork chitterlings (a 
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dish made from pig intestines) was the source of the infection in the other 
outbreak. Both outbreaks involved Y. enterocolitica 4/O:3 as the causative 
agent [108].  
 
2.1.7.3 In environment (including water) 
 
Y. enterocolitica and other Yersinia species are ubiquitous in the natural 
environment and can be isolated from soil, foliage, surface water, sewage 
water and sludge, have been non-pathogenic [109]. However, the vast 
majority of the isolates lacks the classical markers of bacterial virulence and 
is considered nonpathogenic. The possibility for the microorganism to survive 
in this type of environment has been investigated [109].  
 
In a study carried out in Australia, 251 water samples tested by nested PCR. 
Eleven samples from 4 separate locations tested positive. One of the PCR-
positive results was confirmed by culture. Some waterborne cases/outbreaks 
caused by the bacterium have been reported from North America. The 
isolated strains belonged to bioserotype 1B/O:8, a bioserotype not commonly 
isolated in the United States after the 1980. Bioserotype 4/O:3 was isolated 
from well water in a small family outbreak of gastroenteritis in Ontario, 
Canada [110].  
 
2.1.7.4 In human 
 
Y. enterocolitica was first recognized as a human pathogen in the 1930 [24]. 
Bioserotype 4/O:3 is the most common type of Y. enterocolitica recovered 
from humans with diarrhea. The highest incidence of enteritis caused by this 
type has been found in young children. However, Morris et al., have also 
isolated strains of bioserotype 4/O:3 at a high rate from asymptomatic 
children [111].  
 
 23
The infection rate is probably much higher since only the most serious cases 
are registered. Only a few isolates of O:9 and O:5,27 are reported annually. 
During the 1980, several countries in Europe reported a dramatic increase in 
the number of recovered human cases. In the beginning of the 1990, the 
diagnosed yersiniosis cases in Sweden reached numbers exceeding 1000 
and in 1996 it was classified a notifiable disease. In the United States, the 
Center for Disease Control and Prevention (CDC) estimates about 17,000 
annual cases, i.e. an incidence of 6 per 100,000 inhabitants [112]. 
 
2.1.8 Yersinia enterocolitica infections 
 
2.1.8.1 In animals 
 
Several reports have been presented on isolation of Y. enterocolitica strains 
from a variety of animals, but descriptions of observed clinical manifestations 
or patho-anatomical changes are sparse. Sporadic, small outbreaks of 
enteritis caused by Y. enterocolitica have been reported in chinchillas, hares, 
sheep and goats [101]. However, both biochemical and serological patterns 
deviated from those of human strains. 
 
Pigs have been experimentally infected with bioserotype 4/O:3 in several 
studies [113]. Strains of Y. enterocolitica 4/O:3 have been shown to cause 
gastroenteritis in new-born, colostrum-deprived piglets, whereas full-term 
colostrum-fed piglets seem to be quite resistant to infection. In colostrum-fed 
piglets, colonization was typically restricted to the throat and intestinal tract 
without development of serious illness. Fattening pigs have been shown to 
excrete high numbers of Y. enterocolitica 4/O:3 in faeces for several weeks 
after infection mostly without any symptoms. However, Thibodeau et al,. 
demonstrated that the fecal shedding stops soon after ingestion of bacteria 




2.1.8.2 In humans 
 
Y. enterocolitica can cause gastro-intestinal symptoms ranging from mild 
self-limited diarrhea to acute mesenteric lymphadenitis evoking appendicitis. 
Sometimes focal disease, such as pharyngitis, cellulitis, abscess, pneumonia 
and meningitis, may occur without gastro-intestinal illness [30]. The 
incubation period of Y. enterocolitica enterocolitis ranges from 1 to 11 days. 
The minimal infective dose for humans has not been determined. Symptoms 
of enterocolitis typically persist for 5 to 14 days, but they may occasionally 
last for several months. The duration of the excretion of the organism in stool 
has been reported to range from 14 to 97 days. The clinical manifestations of 
infection depend on factors such as the age and physiological state of the 
host and the pathogenic properties of the particular strain [30].  
 
Most commonly, Y. enterocolitica infections occur in young children [25]. In 
patients under 5 years of age, yersiniosis presents as diarrhea, often with 
low-grade fever and sometimes with abdominal pain. The symptoms can 
even be so faint and short-lived that yersiniosis is not diagnosed, despite 
fecal carriage. In older children and young adults, acute yersiniosis can be 
present as a pseudo-appendicular syndrome, which is frequently confused 
with appendicitis [17].  
 
Sepsis is a rare complication of Y. enterocolitica infection, except in patients 
who have a predisposing underlying disease or are in an iron-overloaded 
state [115]. Sepsis can also occur during blood transfusion. One source of Y. 
enterocolitica -contaminated red blood cell concentrate has been reported to 
be a blood donor with asymptomatic bacteremia [116]. Normally, yersiniosis 
is a self-limited disease, but sometimes long-term sequelae, including 
reactive arthritis, erythema nodosum, glomerulonephritis and myocarditis, will 
occur. Post-infection complications usually develop within one week to one 
month of initial infection, and these may be the only obvious clinical 
manifestation of Yersinia infection [17].  
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2.1.9 Epidemiology and disease outbreaks  
 
The distribution of Y. enterocolitica appears to be temperate, involving the 
United States, Northern Europe, Canada, and Australia. There is also some 
speculation that the seasonal incidence of disease peaks in cooler months. 
These observations have been linked to the fact that the organism is cold-
adapted and can survive and grow at 4oC. In Europe the serotypes O:3 and 
O:9 predominate, whereas in the United States serotype O:8 is the most 
frequently isolated. Serious disease has been linked, however, to all three of 
these serotypes, regardless of geographic locale [28].  
 
Epidemic outbreaks are usually fled to particular serotypes, but it is likely that 
other serotypes are involved in the sporadic occurrence of enterocolitis [117]. 
Y. enterocolitica is primarily a zoonotic disease. Humans are incidental hosts. 
Illness is usually sporadic and outbreaks are rare [118]. 
 
2.1.9.1 Outbreak locations 
 
In Denmark, to examine the general frequency of household outbreaks, the 
authors performed a retrospective search among cases of the five most 
frequent gastrointestinal bacterial pathogens in Denmark, a country of 5.3 
million inhabitants. This was done for 57,667 cases registered from 1991 to 
2001 by finding all cases that shared addresses and became infected within 
3 weeks of one another. The percentage of cases that were part of 
household outbreaks was found to be 2.0% for Y. enterocolitica [119].  
 
In New York, USA, In September and October, 1976, an outbreak of illness 
due to chocolate milk contaminated with Y. enterocolitica resulted in 
hospitalization of 36 children, 16 of whom had appendectomies [121]. An 
epidemiologic investigation demonstrated that illness was associated with 
drinking of chocolate milk purchased in school cafeterias, and Y. 
enterocolitica O:8 was subsequently isolated from the milk. The investigation 
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suggested that the bacterium was introduced at the dairy during the mixing 
by hand of chocolate syrup with previously pasteurized milk [121].  
 
Gastrointestinal disorders of varying severity were observed in 239 (53%) of 
455 campers and staff members at a coed summer camp in Sullivan County, 
New York, during July 1981. Five of seven hospitalized patients had 
appendectomies before the disease was recognized as yersiniosis. Yersinia 
enterocolitica serogroup O:8 (American strain) was isolated from 37 (54%) of 
69 persons examined, including the head cook and 3 others of the 11-person 
kitchen staff. Of 48 food, water, and environmental samples collected from 
the camp area, Y. enterocolitica isolates belonging to the same serogroup 
and biogroup as the human isolates were recovered from dissolved 
powdered milk, a milk dispenser, and turkey chow mein [120].  
 
This laboratory finding supported the epidemiological data indicating a 
correlation between consumption of these foods and illness. Y. enterocolitica 
isolates of the same biogroup as the O:8 isolates but belonging to serogroup 
O:34 were also isolated from six campers and two samples of dissolved 
powdered milk [120].  
 
In June and July 1982, a large interstate outbreak of Y. enterocolitica 
infections caused by an unusual serotype occurred in Tennessee, Arkansas, 
and Mississippi. In three separate case-control studies, drinking milk 
pasteurized by plant A was statistically associated with illness. In a survey of 
randomly chosen households, 8.3% of persons who recalled having drunk 
milk from plant A during the suspect period experienced a yersiniosis-like 
illness. Inspection of the plant and cultures of the available raw and 
pasteurized milk did not reveal the source or mechanism of contamination or 




Although outbreaks of enteric disease caused by pasteurized milk are rare in 
the United States, the ability of Y. enterocolitica to grow in milk at 
refrigeration temperatures makes pasteurized milk a possible vehicle for 
virulent Y. enterocolitica. The extent to which milk is responsible for sporadic 
cases of yersiniosis is unknown [121].  
 
Twelve cases of Yersinia infection in infants less than 1 year of age were 
identified in Tennessee with onset from November 15, 2001 to February 15, 
2002. All cases were identified by stool culture. Six cases occurred in 
December, and 10 were medically evaluated in the same city. All case-
patients were black. In comparison, 49% of the population of the urban 
county in which the outbreak was identified is black. In this case-control study 
of Y. enterocolitica infections among black infants, chitterling preparation was 
significantly associated with illness (p less than 0.001). Of 13 samples of 
chitterlings tested, 2 were positive for Yersinia intermedia [122]. 
 
In Japan. On 3 August 2004, a local public health bureau in Nara Prefecture 
received a report of a food poisoning case at a nursery school. Of 182 
nursery school children, 42 were infected; none of the 20 staff members were 
infected. From clinical symptoms and bacterial isolations, the patients were 
diagnosed as having been infected with Y. enterocolitica [123].  
 
Y. enterocolitica serotype O:8 was isolated from 16 of 32 patients, none of 
the 17 childcare workers, and none of the 3 cooking staff members from 
whom stool samples were taken. In addition, 5 strains were obtained from 
medical facilities. Y. enterocolitica serotype O:8 was also isolated from 
salads containing apples, cucumbers, ham, potatoes, carrots, and 






2.1.9.2 Possible transmission routes of sporadic Yersinia enterocolitica 
infections 
 
Pigs are considered to be the main source of human Y. enterocolitica 4/O:3 
infections, even though a definite connection between isolates from pigs and 
human infections has still to be established. Elevated serum antibody 
concentrations have been found among people involved in swine breeding or 
pork production, suggesting a direct transmission of this bacterium from pigs 
to humans. In Finland, slaughterhouse workers and pig farmers were 
observed to have elevated antibody levels to Y. enterocolitica O:3 twice as 
frequently as grain- or berry farmers. Similar differences have also been 
discovered between people involved in swine slaughtering practices and 
office personnel in Norway [124]. 
 
Pet animals have also been suspected of being sources for human infections 
because of their close contact with humans. However, direct transmission 
from pets to humans has yet to be proven. The most common transmission 
route of pathogenic Y. enterocolitica is thought to be fecal-oral via 
contaminated food, although pathogenic isolates have seldom been 
recovered from food samples [125].  
 
Direct person-to-person contact has not been demonstrated, but Lee et al., 
reported Y. enterocolitica O:3 infections in infants who were probably 
exposed to infection by their caretakers [108]. Indirect person-to-person 
transmission has apparently occurred in several instances by transfusion of 
blood products [126]. In these cases, the most likely source of Yersinia has 







2.2 Aeromonas hydrophila 
 
2.2.1 Historical background and taxonomy 
 
Species of Aeromonas are Gram-negative, non-spore-forming, rod-shaped, 
facultatively anaerobic bacteria that occur ubiquitously and autochthonously 
in aquatic environments. Some species are pathogenic for animals and 
humans.  Although historically the Aeromonas genus has been placed in the 
family Vibrionaceae, there have been proposals to place it in its own family, 
the Aeromonadaceae. The aeromonads share many biochemical 
characteristics with members of the Enterobacteriaceae, from which they are 
primarily differentiated by being oxidase-positive [16].  Earlier literature 
focused mainly on A. hydrophila but several later studies have shown that the 
majority of clinical isolates fall within three species [127]. 
 
The genus Aeromonas includes at least 13 genospecies, among which are 
the mesophilic A. hydrophila, A. caviae, A. sobria, A. veronii, and A. 
schubertii, and the non-motile, psychrophilic A. salmonicida. A. salmonicida 
is a fish pathogen and has not been associated with human infection. By 
contrast, the mesophilic species have been associated with a wide range of 
infections in humans [128]. Although members of the genus have classically 
been divided into three biochemically differentiated groups (typified by A. 
hydrophila, A. caviae, and A. sobria), these contain a number of 
genospecies, to which new species have been added [129].  
 
The current taxonomy of the genus Aeromonas is based upon DNA-DNA 
hybridization and 16S ribosomal DNA relatedness studies. The genera of the 
family Aeromonadaceae now include Aeromonas, Oceanimonas, 
Oceanisphaera, and Tolumonas (incertae sedis). The current 
genomospecies and phenospecies within the genus Aeromonas are A. 
hydrophila ssp. dhakensis (subsp. nov.), A. hydrophila ssp. ranae (subsp. 
nov.), A. culicicola (sp. nov.), A. simiae (sp. nov.), and A. molluscorum (sp. 
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nov.) have been proposed as new species and subspecies of Aeromonas, 
and more will undoubtedly be described [16].  
 
The A. hydrophila causing human diseases are associated with a variety of 
infections including septicemia, wound infections, meningitis, peritonitis, and 
hepatobiliary infections. Some strains of Aeromonas produce enterotoxins 
responsible for causing gastroenteritis in humans, since these bacteria are 
widely distributed throughout the environment in water and foods, especially 
during summer months [128].  
 
The genus Aeromonas consists of straight, coccobacillary to bacillary gram-
negative bacteria with rounded ends measuring 0.3-3.5 mm [16]. They occur 
singly, in pairs, and rarely as short chains. Motile strains produce a single 
polar flagellum, though peritrichous or lateral flagella may be formed on solid 
media by some species. Aeromonas spp. are facultatively anaerobic, 
catalase positive, oxidase positive, chemoorganotrophic bacteria that exhibit 
both oxidative and fermentative metabolism on carbohydrates [129].  
 
Serotyping is based upon somatic (O) antigen determinants as described by 
Sakazaki and Shimada [130]. Several typing schema have been proposed 
[131], but only one comparison study of two of these schema has been 
published [132]. The schema of Sakazaki and Shimada recognizes 44 
serogroups, with an additional 52 provisional serogroups proposed by Albert 
[130]. Aeromonas spp. are found to be serologically heterogeneous, with 
individual serogroups found in more than one species. Most type and 
reference strains were not serologically representative of a genomospecies. 
Three serotypes predominate in clinical samples, O:11 (24%), O:16 (14%), 
and O:34 (10%) [128].  
 
Korbsrisate characterized the distribution of A. hydrophila serogroups in 
clinical samples and developed polyclonal antibodies for rapid identification 
of clinical isolates by direct agglutination. Only 50% of strains fell into the 
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common serogroups O:11, O:16, O:18, O:34, or O:83. Rough strains (15.2%) 
and untypable strains (2.3%) reduced the effectiveness of serotyping for 
identification of clinical strains. A polyvalent antiserum was produced that 
resulted in positive agglutination of 102 or 105 strains, for a calculated 
sensitivity of 97.1% and specificity of 90.7%. This test could be useful in rapid 
identification of aeromonads to genus where they are isolated from samples 
that may also contain vibrios [133]. 
 
2.2.2 Ecology and host range 
  
A.  hydrophila are found worldwide in aquatic environments, including ground 
water, surface waters, estuarine and marine waters, drinking water, and 
wastewater [134].  A. hydrophila are found in foods, including fresh grocery 
produce, seafood, raw meats, packaged ready-to-eat meats, cheese, and 
milk [135].  While Aeromonas spp. are not considered fecal bacteria, they are 
present in the feces of healthy animals and humans, presumably as the 
result of ingestion of food and water containing these organisms [136]. 
 
They are present in high numbers in sewage before and after treatment, thus 
they have been proposed as an indicator of sewage-contaminated surface 
water. A. hydrophila may colonize drinking water distribution systems and 




Although most of the active research on Aeromonas species concerns the 
identification of virulence factors or mechanisms potentially operative in 
human or animal infections, only one factor, the S layer of A. salmonicida, 
has been linked to the overt pathogenicity of this species in causing serious 
infections in fish. Most of the other reputed virulence factors produced by A. 
hydrophila have been linked to pathogenicity in humans by inference; that is 
similar molecules have been shown to play important roles [128].  
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Virulence factors are present in two forms, cell-associated structures, and 
extracellular products. Among the cell-associated structures are pili, flagella, 
outer membrane proteins, lipopolysaccharide, and capsules. The major 
extracellular products include cytotoxic, cytolytic, hemolytic, and enterotoxic 
proteins [128,138]. 
 
2.2.3.1 Cell-associated structures 
 
A. Pili. While early studies had indicated that a number of Aeromonas strains 
were piliated, a detailed analysis of such structures was not undertaken until 
recently. A. hydrophila produce an array of filamentous structures, including 
short rigid, and long wavy pili, and polar and lateral flagella. Removal of pili or 
neutralization of attachment sites by homologous antibody treatment limits or 
defeats adherence properties in cell culture systems. Polar flagella and 
lateral flagella were described by Rabaan et al., and Kirov et al., [139,140]. 
Polar flagellins function as adhesions, while lateral flagellins are thought to 
serve as colonization factors [141].  
 
B. Capsule production has been reported for A. hydrophila serogroups, but 
the function of capsule material is vague. It is presumed to resist complement 
activity and perhaps enhance adherence [142].  
 
C. S-layers (originally termed A-layer in A. salmonicida) are paracrystalline 
structures made up of identical protein subunits that are translocated across 
the cell membrane and assembled on the cell wall surface via an interaction 
with O-polysaccharide side chains of lipopolysaccharide. A. hydrophila stains 
producing S-layers are more pathogenic for fish, but the role of S-layer in 
human infection is not clear. Studies suggest that strains containing S-layers 
autoagglutinate [143].  
 
D. Outer membrane proteins (OMP) of A. hydrophila are rather 
heterogeneous, although most strains produce a 36 k Da protein. In addition, 
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iron-starved A. hydrophila cells synthesize new OMP of 68 – 93 k Da. Mittal 
et al., reported that a group of A. hydrophila, virulent fish pathogens, 
exhibited a number of unique phenotypic properties that were thought to be 
cell-surface associated, including autoaggregation during growth in static 
broth culture [144]. 
 
E. Lipopolysaccharide (LPS) endotoxin. The O-antigen structure of 
virulent strains of A. hydrophila has been shown to have many points of 
similarity with that of the O-antigen of A. salmonicida. LPS endotoxin is an 
important component of the outer membrane of A. hydrophila, which has 
been shown to enhance red-leg disease in frogs. However, the importance of 
this toxin in human infections has not yet been elucidated [145]. 
 
2.2.3.2 Extracellular products 
 
Most aeromonads elaborate a large number of extracellular enzymes that 
actively degrade a variety of complex protein, polysaccharide, muco-
polysaccharide, and lipid-containing molecules. Although these enzymes are, 
in many instances, useful in identification as in the case of DNase, their roles 
in the physiologic functions of the bacterium or in virulence are largely 
unknown. To date, with minor exceptions, most extracellular factors produced 
by Aeromonas species are thought to play a role in gastrointestinal disease; 
this association will remain unproved until suitable models are developed for 
their study. Another reason for the difficulty in understanding the role that 
various extracellular enzymes play in pathogenesis concerns their 
multifunctional nature. A prime example of this latter problem is the 
Aeromonas hemolysin(s), which appears to be not only cytolytic but also 
enterotoxigenic [128]. 
 
A. Hemolysins. Probably the most striking cultural feature displayed by 
many Aeromonas strains is their ability to hemolyze erythrocytes when grown 
on a suitable agar-based medium.  This characteristic is principally 
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associated with certain strains belonging to the phenospecies A. hydrophila 
and A. sobria and is linked to the elaboration of an extracellular hemolysin(s) 
[146]. Such a hemolysin, which typically belongs to a larger group of pore-
forming bacterial cytolysins, causes leakage of the cytoplasmic contents from 
target cells via disruption of the normal integrity of the cell membrane [147]. 
The end result is death, either by osmotic lysis or by a nonosmotic process. 
At least two major classes of hemolysins expressed by Aeromonas strains 
have been reported. One class, originally termed "aerolysins" by Bernheimer 
and Avigad [128], comprises typical beta-hemolysins that produce clear 
zones of hemolysis on blood agar.  
 
The aerolysin is synthesized in a precursor form, from which the signal 
sequence is removed prior to export across the bacterial outer membrane. A 
second class of hemolysins, termed alpha-hemolysins, has been primarily 
studied by a number of Swedish investigators. The alpha-hemolysin is 
elaborated during the stationary phase and is not expressed when 
temperatures exceed 30°C. When observed on blood agar, this hemolysin 
produces an opaque, incomplete type of hemolysis that is often seen as the 
inner hemolytic zone of a strain producing "double-zone" hemolysis. Both 
alpha- and beta-hemolysins have observable but different effects on cell 
culture lines, although the effect of the beta-hemolysin appears irreversible 
[128]. 
 
B. Proteases are enzymes that are capable of cleaving peptide bonds. A 
number of extracellular proteases produced by gram-negative bacteria are 
thought to play important roles in pathogenesis and virulence. Aeromonas 
isolates secrete at least four or five different proteases, as determined of pH 
optima and substrate specificities. Two major proteases produced by A. 
hydrophila. One enzyme is a heat-stable protease that is inactivated by 
EDTA and appears to belong to the general class of thermostable 
metalloproteases; the other protease is heat labile (56°C, 30 min) and 
belongs to the thermolabile serine protease family, the metallo- and serine 
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proteases are involved in toxin activation and have a protective role in 
inimical environments [128].   
 
C. Siderophores are low-molecular-weight compounds with high affinities 
(binding capacities) for various organic and inorganic forms of iron, 
particularly under iron-limiting conditions. These compounds are thought in 
many instances to play important roles in the establishment of infection, and 
the hydroxymate class of siderophores has been associated with gram-
negative bacteria. Almost all strains of A. salmonicida, A. hydrophila, A. 
sobria, and A. caviae studied elaborate one or more types of siderophores 
[148,149]. 
 
2.2.4 Factors affecting growth 
 
A. hydrophila have their natural habitat in water and grow over a wide 
temperature range. Because A. hydrophila grow between 0ºC and 45ºC, with 
a temperature optimum of 22ºC to 32ºC, there are few environmental habitats 
where they are not found. Both high and low [150] survival rates have been 
reported. Nutrient availability, temperature, and water activity most affected 
growth rates. Growth was optimal at 30ºC at pH 7 and a water activity of 
0.99. A. hydrophila have been shown to grow in foods held at refrigerator 
temperatures [151].  
 
Growth temperature is an important feature in differentiation of clinical and 
environmental strains. Approximately half of clinical isolates show some 
growth at 4-5 ºC, all food isolates grow at this temperature. While most 
clinical strains grow at 42 ºC, only a few isolates from vegetables stored at 
5ºC grew at elevated temperature. The growth temperature range for A. 
hydrophila is from 4 to 44ºC, but individual strains typically have a restricted 
growth range according to their ecological niche, and growth of a strain at 
both extremes of the range are rare [14]. A. hydrophila are considered heat 
sensitive with respect to other foodborne pathogens.  
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A. hydrophila tolerate high pH well and this feature has been exploited by 
using alkaline peptone water at pH 8.6 for sample enrichment. A. hydrophila 
grow at pH 5.8 or higher, and may survive at pH 4.6 or higher according to 
computer modeling using Food Micromodel [151]. Species-specific acid 
tolerance is know to occur, since Aeromonas spp. grown on glucose or other 
simple sugars produces sufficient acetic acid to auto-sterilize a broth culture 
within 48 hr. in weakly buffered systems. This metabolic activity has been 
called the suicide phenomenon [152].  
 
Modified atmospheres are increasingly being used in food packaging. Pin et 
al., studied the response of A. hydrophila to various combinations of pH, 
temperature, and CO2 and O2 concentrations. The results were used to 
develop and validate a predictive model for growth and death estimates 
under modified atmospheres at refrigerator temperature. Reduced oxygen 
levels do not exert a detrimental effect on survival and growth of 
aeromonads, and they may be isolated from vacuum packed foods [153].  
 
2.2.5 Isolation and identification of pathogenic Aeromonas hydrophila 
from clinical, foods and environmental samples 
 
2.2.5.1 Isolation and enumeration 
 
Isolation of A. hydrophila from food and environmental samples provides a 
challenge because of the presence of competing bacteria and the possibility 
of sample matrix interference with sample preparation and culture methods. 
The use of dilution schemes and enrichment media facilitate isolation of A. 
hydrophila from heavily contaminated samples such as sewage, sludge and 
sewage effluents. Palumbo et al., compared several culture media for 
isolation and enumeration of aeromonads from water samples and concluded 
that ampicillin dextrin agar (ADA) produced the best overall results [154].  
 
 37
Several culture enrichment and culture media have been evaluated for 
isolation of A. hydrophila from foods. Starch ampicillin agar (SAA) and bile 
salts inositol brilliant green agar (BIBG) with prior enrichment in tryptose 
broth containing ampicillin (TSB-30) (ampicillin 30 mg/L) [155] are 
recommended, together with commercially available media such as 
Aeromonas Medium (Ryan’s Medium) [156]. Starch glutamate ampicillin 
penicillin (SGAP-10) medium was used to isolate aeromonads from sewage 
sludge. This medium is highly selective, and it has been used to isolate A. 
hydrophila from foods and other challenging matrices. Samples are prepared 
in dilution, inoculated into culture media with or without enrichment, and 
incubated aerobically at 35ºC for 24-48 hr. Colonies are screened by 
performing a spot oxidase test and identified using biochemical methods or 
commercially-available bacterial identification kits [157]. 
 
Isolation of A. hydrophila from contaminated samples such as feces require 
the use of selective and differential plating media such as MacConkey agar, 
cefsulodin irgasan novobiocin (CIN) agar, or blood ampicillin agar (10 mg/L 
ampicillin) [158]. To facilitate recovery of A. hydrophila from heavily 
contaminated specimens such as feces, enrichment broths such as alkaline 
peptone water are incubated overnight and subcultured to blood ampicillin 
agar and CIN agar. Culture plates are incubated aerobically at 35ºC for 24-48 
hr. Aeromonas spp. produce characteristic colonies, with or without 
hemolysis on blood agar, and colonies may be quickly screened using the 
spot oxidase test. Oxidase positive colonies are further screened using tube 
biochemicals or by inoculation of a cell suspension into one of the 




Commercial systems for bacterial identification are notoriously inaccurate for 
identification of Aeromonas spp., since they do not incorporate the key 
substrates necessary for correct identification [160]. Vivas et al., compared 
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MicroScan Walk/Away in conjunction with the MicroScan Combo Negative 
type 1S panels with conventional biochemical methods for identification of 85 
environmental, clinical and reference strains of Aeromonas spp. Using the 
MicroScan Combo Negative type1S substrate panel, 67 of 88 (78.8%) of 
strains were correctly identified, 4 of 88 (4.7%) of strains were incorrectly 
identified, and 10 of 88 (11.8%) of strains represented rare biotypes that 
could not be identified [161].  
 
 Carnahan and Joseph found that colistin resistance could be used as an 
additional phenotypic marker for identification of aeromonads. A. hydrophila 
group is 85.8% resistant, while A. caviae group is 2.1% resistant. When 
colistin was included in a 14 panel test format, 96.2% of strains could be 
identified to phenospecies and 93.6% of strains could be identified to 
genomospecies [162].  
 
Canonica et al., used whole cell fatty acid analysis (FAME) by gas-liquid 
chromatography to correctly classify A. hydrophila, A. sobria, and A. caviae. 
While this method offers the advantages of an instrumental method with 
autosampling for unattended operation, the reliability of identifications does 
not compare to newer genomic methods [163].  
 
2.2.6 Confirmation of pathogenicity 
 
One of the major drawbacks in studying virulence determinants related to 
Aeromonas pathogenicity has been the inability to establish appropriate 
organ or animal models that faithfully reproduce the specified disease 
observed in vivo. This situation is particularly acute in the case of Aeromonas 
associated gastroenteritis. Establishing such models is critical for identifying 
strains of high- and low-virulence potential and for comparing extracellular 
and cell-associated factors associated with these strains which lead to the 
recognition of determinants and gene products involved in microbial 
pathogenicity [128]. Once virulence determinants are identified, phenotypic 
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markers that allow accurate and rapid identification of pathogenic strains and 
the epidemiology associated with such infections can be sought [128]. 
 
2.2.6.1 Animal tests 
 
Most investigations determining the relative pathogenicities of individual 
Aeromonas strains have used either mouse or fish models [149,164] for 
assessing relative virulence, although limited studies have also been 
performed with chicks and turkey poults [128]. Values obtained from such 
investigations indicate that between 10- and 1,000-fold fewer bacteria are 
required to produce mortality in susceptible fish than in susceptible mice.  
 
2.2.6.2 Phenotypic tests 
 
While inherent pathogenic differences do exist among aeromonads, few 
virulence phenotypic markers reported in the literature go beyond the 
definition of pathogenicity at the phenospecies level. One group of major 
interest, however, is Aeromonas serogroup O:11 strains, which are primarily 
associated with severe invasive disease in both humans and animals [165]. 
These strains are characterized by their autoagglutination or aggregation in 
broth, the presence of an unusual LPS side chain architecture, and the 
possession of a SAP (surface array protein) in the form of an S layer [166].  
Such strains, predominantly found in the A. hydrophila and A. sobria 
phenospecies, can be recognized in the clinical laboratory by phenotypic and 
serologic tests [165].  
 
2.2.6.3 Genotypic tests 
 
Molecular systems such as PCR, DNA hybridization, microarrays of DNA 
probes and fluorescent in situ hybridization (FISH) have been developed for 




2.2.7 Prevalence of Aeromonas hydrophila 
 
2.2.7.1 In animals 
 
Aeromonas spp. have been recognized as animal pathogens since they were 
first isolated from diseased frogs and fish. They are now recognized to cause 
disease in birds and domestic animals [167]. A. hydrophila and A. 
salmonicida cause hemorrhagic disease, ulcerative disease, furunculosis, red 
sore disease and septicemia in fish. A. hydrophila has been isolated from 
diseased turtles, alligators, snakes, and frogs [168]. Populations in animals 
probably reflect the presence of A. hydrophila in their feed and water.  In their 
study of Aeromonas spp. in the feces of domestic animals, Figura and Marri 
isolated A. hydrophila more frequently than A. caviae. Stern et al., isolated 
aeromonads from 1 of 32 cows and 3 of 21 turkeys, but none were isolated 
from 22 pigs or 24 sheep. Gray and Stickler reported finding predominantly 
A. hydrophila in cow feces and A. caviae in pig feces. Diet and water sources 
influenced recovery of A. hydrophila from feces of domestic animals. 
Aeromonas spp. have been isolated from feces, bedding, and drinking water 
of health cows and pigs. They survive in soil for months. Both healthy and 
diseased animals shed Aeromonas spp. in feces [169].  
 
Nayduch et al., proposed that houseflies could serve as vectors for 
transmission of Aeromonas spp. since the bacteria multiplied in the gut and 
persisted for several days. Fly to fly transmission was demonstrated and 
transmission of Aeromonas spp. from fly to food was observed [170]. The 
use of medicinal leeches (Hirudo medicinalis) to treat vascular infiltration in 
surgical wounds has been recognized as a risk factor for A. hydrophila 
infections since 1983, and there are numerous reports of cellulitis and 





2.2.7.2 In foods  
 
A. hydrophila have been isolated from fish, shellfish, meats, dairy products, 
and fresh vegetables, few foodborne outbreaks have been reported [14]. A 
growing body of epidemiological evidence supports the possibility of 
aeromonads causing foodborne gastroenteritis. While a plethora of putative 
virulence factors has been postulated and demonstrated in food isolates, the 
exact role and mechanism of aeromonads in causing diarrheal illness has not 
been elucidated. Evidence suggests that a high infective dose is necessary 
to produce gastrointestinal disease in a susceptible host, and the fact that 
aeromonads may survive and grow at refrigerator temperatures provides a 
reservoir of bacteria that may achieve an infective dose when foods are 
mishandled [172].  
 
United States Food and Drug Administrator (USFDA) reported A. hydrophila 
in fresh and fresh cut produce, and aeromonds have been isolated from 
lamb, oysters, cheese and raw milk, and fish and seafood [173]. Szabo et 
al., isolated Aeromonas spp. from 70 of 120 samples of lettuce in Australia. 
Aeromonads are found in ready to eat foods, including seafoods [174]. 
Studies published before 1990 relied upon phenotypic identification, while 
several studies published after that time identified isolates to hybridization 
group. While hybridization groups containing virulence factors are found in 
environmental samples and foods, aeromonads only cause gastroenteritis 
when their presence exceeds an infective dose for a susceptible host [14].  
 
2.2.7.3 In environment (including water) 
 
There are few studies of A. hydrophila in soil apart from the contribution of 
water. World Health Organization (WHO) reported the presence of 
aeromonads in pasture soil, probably as a contribution from manure [150].  
A. hydrophila forms biofilms on surfaces and may pose a threat of 
contamination in food processing. Researchers found that heat and chlorine 
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were effective against biofilm on stainless steel surfaces, however older 
biofilm was more resistant to heat and less established biofilm. Eight-day old 
biofilm was destroyed by heating to 60ºC and by exposure to 75 mg/L 
chlorine for 1 min [175]. 
 
2.2.7.4 In human 
 
Humans carry A. hydrophila in their gastrointestinal tract both in the presence 
and absence of disease. The rates of fecal carriage in asymptomatic persons 
in developed countries range from 0% to 4.0%, while the isolation rate from 
persons with diarrheal illness ranges from 0.8 to 7.4% [176]. In Southeast 
Asia, asymptomatic carriage rates as high as 27.5% and recovery rates from 
patients with diarrhea as high as 34% have been reported. Among Western 
Peace Corp workers in Thailand, aeromonads were recovered from 8.5% of 
healthy persons and 30.8% of persons with diarrhea [177]. Recovery rates 
among children with diarrhea vary geographically: 0.62 to 4% in Malaysia, 
2.3% in Taiwan, and 4.8% in Switzerland, [178-180].  
 
Sinha et al., reported Aeromonas spp. in 6.5% of all patients in India [181], 
and Chan et al. reported Aeromonas spp. in 6.9% of adult patients with 
acute diarrhea in Hong Kong [182]. Seventeen of 2,565 stool samples 
(0.66%) were positive for Aeromonas spp. [183]. Agger et al., reported A. 
hydrophila in 1.1% of stools in Wisconsin [184], and Moyer reported a fecal 
isolation rate of 7.1% in Iowa. [185].  
 
 
The clinical significance of isolates in these surveys is not clear, even when 
all patients in the surveyed population had diarrhea. Enteropathogenicity is 
influenced by growth temperature, where strains of O:34 grown at 20ºC 
exhibit enhanced virulence over strains grown at 37ºC. Strains isolated at 35-
37ºC, the typical incubation temperature used in clinical laboratories may 
produce false negative tests for virulence factors, making the retrospective 
assessment of clinical significance impossible [186].  
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2.2.8 Aeromonas hydrophila infections 
 
 
2.2.8.1 In animals 
 
A. hydrophila infection of aquatic animals has been recognized for over 100 
years, but they are less commonly recognized in other vertebrates. While 
many animals shed aeromonads from their gastrointestinal tract, there is no 
evidence that they suffer from gastrointestinal disease. Aeromonas spp. 
cause outbreaks of disease and represent an economic threat to the 
aquaculture industry.  
 
A. hydrophila has been reported to cause septicemia in snakes, turtles, and 
frogs [187-189]. Forga-Martel et al., reported a case of infectious abortion 
caused by A. hydrophila in a mare. Contamination from an adjacent dairy 
farm was suspected as the source of infection for the mare and 
transplacental infection was thought to result in fetal sepsis and abortion 
[169].  Disease in aquatic animals is characterized by hemorrhagic lesions, 
ulcers, and septicemia in frogs and fish [189,190]. Paniagua et al., 
determined that doses of 7 log10 CFU of A. hydrophila (72% of strains) 
infected intramuscularly produced disease in trout [191].  
 
2.2.8.2 In human  
 
A. hydrophila has received particular attention because of its association with 
human diseases. It has been isolated form both polluted and unpolluted 
bodies of water through out the world [192]. A study showed that Aeromonas 
spp. was extremely common contaminants of human foodstuffs and that 
some of the strains appear to be virulent. In their study most of the toxigenic 
strains were isolated from seafood and they suggested that seafoods were 
potential sources of virulent aeromonads. Therefore, in cases of foodborne 
bacterial illnesses in which oysters are implicated, Aeromonas spp. should be 
included in the general screening for causative microorganisms [190].  
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A common source of A. hydrophila in outbreaks of gastroenteritis is from 
water supplies such as mineral springs, seawater environments, chlorinated 
and unchlorinated domestic supplies and watersheds polluted by sewage 
effluents. Sources other than water from which this organism can be readily 
isolated include seafood, foods of terrestrial animal origin such as meats, 
dairy products and poultry and vegetables. Asymptomatic and 
immunocompromised human carriers involved with handling of foods are 
another potential source. The presence of A. hydrophila in the food chain 
should not be ignored. Aeromonas species are regarded as controversial 
primary pathogen but several worldwide investigations clearly now indicate 
that at least some strains are clearly enteropathogens and few cases are 
linked to gastroenteritis [193].  
 
Although the incidence of Aeromonas in foods is high, they vary between 
countries and also among the type of strains. Two factors appear to be 
affecting the significance of A. hydrophila as a re-emerging pathogen. The 
first is the consumer driven demand for less processed and more natural 
foods containing fewer additives, there in growing emphasis on, refrigeration 
as the primary means for controlling microbial growth in food. The second 
point is that during the warm season there is an increase in water associated 
A. hydrophila strains also in some cases associated with an increase in 
gastroenteritic patients [193].  
 
Gastroenteritis caused by A. hydrophila has been documented, and the 
incidence of gastroenteritis tends to be higher in summer than other seasons 
[127]. A. hydrophila may be present in the gastrointestinal tract of humans, 
and most epidemiological studies show higher numbers in stools of patients 
with gastroenteritis than in asymptomatic individuals. Acute self-limiting 
diarrhea occurs in children, and chronic gastroenteritis or enterocolitis may 
occur in children and the elderly. The presentation of gastroenteritis caused 
by aeromonads includes various combinations of fever, vomiting, and 
increased fecal leucocytes or erythrocytes [128].  
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According to Kirov, the majority of aeromonads associated with 
gastroenteritis are A. veronii biovar sobria (HG-8/10), A. hydrophila (HG-1), 
and A. caviae (HG-4), though A. veronii biovar veronii (HG-8/10), A. trota 
(HG-13), and A. jandaei (HG-9) occur occasionally. Gastroenteritis attributed 
to A. hydrophila was characterized by acute watery diarrhea, vomiting 
abdominal pain, and fever. [194].  
 
Skin and soft tissue infection caused by Aeromonas spp. resulting in cellulitis 
and bacteremia. Skin and soft tissue infections may follow traumatic injury in 
environments where soil and water may contaminate the wound. A review of 
32 foot injuries revealed that at least one-third of cases resulted from 
introduction of aeromonads in soil-contaminated glass, nails, or sticks. 
Infections from severe trauma associated with automobile accidents or other 
accidents resulting in crushing injury, compound fractures, or severe burns 
may lead to osteomylitis, myonecrosis, or gangrene [195].  
 
Necrotizing fasciitis is a rapidly advancing form of cellulitis characterized by 
muscle necrosis. Tsai et al., reported necrotizing fasciitis caused by A. 
hydrophila in patients with suppressed immune systems, burns, and trauma 
in aquatic settings. The case of an 85-year old man with no history of trauma 
suggests that sepsis from an intestinal source resulted in soft tissue infection 
and subsequent necrotizing fasciitis [196]. Furusu et al., reported a fatal 
case of necrotizing fasciitis accompanied by gas production caused by A. 
hydrophila in a 66 year old man who underwent valve replacement surgery 
[197].  
 
Burn infections caused by aeromonads are rare events – only 29 cases have 
been reported in English language literature. These authors reported 5 cases 
of A. hydrophila or A. caviae infections from burns associated with explosions 
(4 of 5) and a campfire accident (1 of 5). In 4 of 5 cases, water was used to 
quench the fire or as a first aid treatment. Ko et al., reported A. hydrophila 
infection in 62-year old female suffered from a flame burn covered by 61% of 
her total body surface area [198].  
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Trauma is most closely associated with Aeromonas wound infections. While 
the typical presentation in persons with normal immune status is cellulitis, 
more serious infections and sepsis can occur. Patients developing 
myonecrosis have a mortality rate exceeding 90%. The significance of A. 
hydrophila as a cause of skin and soft-tissue infections was made abundantly 
clear as a result of the tsunami that devastate Southeast Asia in December 
2004. Among 777 patients hospitalized for injuries suffered as a result of the 
tsunami, 515 had skin and soft-tissue infections and 145 isolates for 305 
patients were A. hydrophila. Many of these infections developed because 
traumatic wounds were not cleaned properly or because of delay in obtaining 
medical care [199].  
 
Pneumonia and lung abscess in adults has been reported. Pneumonia may 
also occur in children, and Kao et al., reported a case of bacteremic 
pneumonia caused by A. hydrophila in a previously healthy 5-year old child. 
Predisposing conditions were present in 11 of 15 (73%) of cases. Reported 
predisposing conditions include alcohol abuse (20%), neurologic disease 
(20%), cardiovascular disease (27%), chronic renal failure (7%), chronic 
obstructive lung disease (20%), traffic accidents (7%), and malignancy (7%) 
[200]. Murata et al., reported fulminant pneumonia caused by A. hydrophila 
in a patient undergoing hemodialysis with chronic renal failure and cirrhosis. 
The source of infection was not determined [201].  
 
Respiratory infections occur in the immunocompetent persons who 
involuntarily aspirate surface water while swimming or as the result of an 
accident [202]. Miyake et al., reported Aeromonas pneumonia from near-
drowning experiences. Respiratory infections may also occur in persons with 
underlying diseases placing them at risk for Aeromonas bacteremia 
originating from an intestinal source. Isolation of A. hydrophila from 
respiratory specimens must be interpreted together with clinical findings, 
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since the upper respiratory and nasopharyngeal tracts may be transitorily 
colonized [203].  
 
Meningitis is a rare complication of extraintestinal infections with A. 
hydrophila [204].  Brouqui and Raoult reviewed endocarditis and found only 
two cases caused by A. hydrophila, both in patients with cirrhosis [205]. 
Osteomyelitis has been reported following compound fractures or crushing 
trauma where wounds were contaminated by soil or water [206]. Liver 
disease is a recognized predisposing factor leading to Aeromonas infection 
resulting from septicemia. Underlying hepatitis B infection and cirrhosis are 
predisposing factors for liver disease. Liver abscess, supperative cholangitis, 
and empyema may occur following septicemia in patients with underlying 
hepatobiliary disease. A. hydrophila was identified in all instances in which 
species identification was performed [207].  
 
Bacteremia resulting from A. hydrophila infection was reviewed by Tsai et 
al., A. hydrophila sepsis is associated with gastrointestinal disease, liver 
cirrhosis, diabetes, malignancy, pancreatitis, trauma, cardiac anomalies, and 
respiratory disease. Sepsis is accompanied by fever, hypotension, jaundice, 
and chills, and complications of Aeromonas infection may include 
intravascular coagulation, purpura fulminans, and ecthyma gangrenosum. 
Disseminated infection progresses rapidly and has a high fatality rate [208].  
 
Peritonitis sometimes occurs as a secondary infection following colonization 
of the intestinal tract, and is also associated with peritoneal dialysis or 
intestinal perforation. Most infections occur in patients with chronic liver 
disease, where the case-fatality rate approaches 60% [206]. Fang et al., 
reported a case of hemolytic uremic syndrome (HUS) caused by A. 
hydrophila in a 23-month old child that occurred six days following an 
episode of bloody diarrhea in a follow-up report [209].  
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The causal role of A. hydrophila in ocular disease must be evaluated in 
conjunction with clinical presentation, since A. hydrophila have been cultured 
from eye swabs of 73-year-old male with a history of myelodysplastic 
syndrome, suffered from periorbital swelling in the eye. Since A. hydrophila 
should be listed as an important pathogen in any soft tissue infection 
including eyelid infection [210]. Septic arthritis caused by A. hydrophila is 
relatively rare [211].  
 
2.2.9 Epidemiology and disease outbreaks 
 
2.2.9.1 Outbreaks locations 
 
A. hydrophila are frequently isolated from drinking water [212], and temporal 
and seasonal associations between presence of aeromonads in drinking 
water and their presence in the stools of patients with gastroenteritis have 
been reported [213]. While some investigators claim that drinking water is 
responsible for outbreaks of Aeromonas gastroenteritis, epidemiological 
evidence linking water ingestion to gastrointestinal illness has been limited to 
untreated drinking water supplies[183]. 
 
Molecular typing studies have shown that the strains most frequently found in 
feces belong to HG-1 and HG-4, while HG-2, HG-3 and HG-5A are more 
commonly found in drinking water and the environment, suggesting that 
environmental strains are fundamentally different from clinical strains. The 
high infectious dose, the differences in temperature optima, and the variation 
in expression of putative virulence factors between clinical and environmental 
strains suggest that outbreaks of gastrointestinal illness resulting from water 
ingestion are unlikely to occur [214].  
 
One report linked exposure to aquarium water to a case of gastroenteritis 
caused by A. sobria with fatal disseminated disease in a 6-month old child 
[215]. A. hydrophila have been reported as the cause of individual cases and 
point source outbreaks of foodborne disease.  Seafood products are among 
the ideal substrates for proliferation of Aeromonas [128].  
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In tropical countries like India, fishery products are contaminated by various 
food-borne pathogens. Pollution and cross contamination levels are very high 
in many developing tropical countries due to lack of infrastructure. It is 
important that fishery products should be maintained free from pathogens 
before consumption. Variations in the incidence level of A. hydrophila, the 
most common aeromonad in seafood can be attributed by secondary 
contaminations such as handling, usage of polluted/non-hygienic water, 
storage of seafood in inadequate facilities etc. Also, A. hydrophila may be 
introduced from water, animal faeces, or food-handlers. The ubiquity of this 
organism means it has the potential to be food-borne [216]. 
 
In United States, food poisoning is responsible for a major loss of economic 
resources, being second to the common cold in causing time lost from work. 
About 35-40% of the reported food-borne outbreaks, which occur in the US 
each year, are of unknown etiology [217]. In the last few years, motile A. 
hydrophila have been included in the list of bacterial species that are 
considered enteric pathogens [218]. Here have also been several reports of 
A. hydrophila contaminated meat, poultry and raw milk but there have been 
few systematic studies on the incidence of Aeromonas spp. in foods although 
one report suggested that these organisms were very common contaminants 
of food [14].  
 
The much higher incidence of Aeromonas spp. in foods purchased at retail 
outlets suggests that the source of contamination may not be faeces and 
there is an increasing evidence that some strains of Aeromonas spp. cause 
diarrhea in human beings and it is likely that uncooked or cross contaminated 
foods act as a source of infection [219]. This organism has been isolated 
from all over the world, and its source is wild fish, and pond cultured edible 
and ornamental fish [220]. A. hydrophila was first reported as associated 
bacteria exclusively with diseased fish. Another known reservoir is shellfish, 
particularly, oysters [221]. Vila et al., reported Aeromonas spp. as the cause 
of diarrhea in 2% of travelers to Africa, Latin America, and Asia [222].   
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2.2.9.2 Possible transmission routes of sporadic Aeromonas hydrophila 
 
A. hydrophila is ubiquitous in the environment and there are multiple 
opportunities for transmission to humans through food, water, animal contact, 
and direct human contact. Extra-intestinal infections are typically acquired 
following trauma in an aquatic environment, and intestinal infections are 
acquired by ingestion of contaminated food or water. Intestinal infections in 
immunocompromised patients may disseminate resulting in septicemia with 
multiple organ involvement. Inhalation of surface water in near drowning 
incidents has been reported to cause pneumonia.  
 
 
A. hydrophila have been recognized as potential foodborne pathogens since 
1984. Kirov reviewed the public health significance of Aeromonas spp. in 
foods, and Merino et al., reviewed aeromonads as emerging pathogens 
present in foods, and are common on foods, especially green vegetables, 
and they are found in raw milk, ice cream, meats, and seafood [150].  
 
Diarrheal disease was associated with drinking untreated well water [223]. 
Many researchers used ribotyping to demonstrate that shrimp ingestion 
resulted in gastroenteritis in the first report of foodborne illness attributed to 
Aeromonas spp. Subsequently, others have shown the same ribotype in well 
water and stools of patients with gastroenteritis. Ribotyping was used to 
demonstrate that a patient with chronic diarrhea carried the same strain for 
years [214], and ribotyping was used to demonstrate person-to-person 
transmission of Aeromonas between a foster child and a foster parent [185]. 
 
 Filler et al., reported a case of acute renal failure in a 6-month old infant 
caused by Aeromonas spp. acquired from aquarium water. Transmission 
among children in daycare centers, nursing homes, and patients in intensive 
care have been reported [150]. Animal-to-person transmission may occur 
through direct contact, or by ingestion of contaminated food products of 
animal origin. Extra-intestinal infections originate from environmental sources 
directly from soil or water contact, or indirectly by ingestion and bacteremic 
dissemination of A. hydrophila from the gastrointestinal tract [224].  
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CHAPTER 3 





a. Autoclave (Tuttnaur 3870 ELV) 
b. Balance (sensitivity of ± 0.1 g) (Mettler tolado) 
c. Binuclear microscope (Olympus ch20BIMF200) 
d. Blinder (Memmolinix) 
e. Freezer (-70°C) (Heraeus) 
f. Fifteen ml plastic bottles 
g. Incubators capable of holding temperatures at 4 ± 1°C, 25 ± 1°C, 28 ± 
1°C, 30 ± 1°C, 32 ± 1°C, 35 ± 1°C and 37 ± 1°C ( Memert BE400, Selecta 
80067) 
h. Inoculating needles and loops 
i. Refrigerator (Kelvinator)  
j. Sewage collection tool (Home made) 
k. Sterile cellulose acetate membrane with a pore size of 0.45 (Millipore) 
l. Sterile scissors, forceps, knives, pipettes, hockey sticks, and other supplies 
m. Sterile tubes and cups 
n. Vortex mixer (Snijers) 




a. Crystal violet (85 µg/ml aqueous solution) 
b. Crystal violet (0.5 mg/ml aqueous solution) 
c. Ferrous ammonium sulfate (1%) 
d. Gram stain kit (Himedia, India) 
e. HCl solution (1 N) 
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f. KOH  (0.25%) in 0.5% NaCl aqueous solution  
g. Kovacs' reagent 
h. Oxidase reagent or reagent-impregnated disc/strip (Himedia, India) 
i. Sterile mineral oil 
j. Sterile Saline (0.85% NaCl) 
k. Voges-Proskauer (VP) test reagents (KOH and Alpha naphthol) 
l. Wayson stain (prepared from basic ingredients) 
 
3.1.3 Media  and biochemical tests 
 
a.  API 20E system (Biomeroux, France) 
b. Brain heart infusion agar 
c. Brain heart infusion broth 
d. Blood agar 
e. Cefsulodin-irgasan-novobiocin (CIN) agar 
f. Christensen's urea agar slants 
g. DNase test agar 
h. Esculin agar 
i. Hektoen Enteric agar 
j. Kligler's Iron agar (KIA) slants 
k. MacConkey agar 
l. Salmonella Shigella (SS) agar 
m. Phosphate Buffered Saline (0.01 M) (PBS, pH 7.6) 
n. Simmon's Citrate agar slants  
o. Thioglycollate broth 
p. Trypticase Soy Broth (TSB) 
q. Xylose Lysine Deoxycholate agar (XLD) 








3.2.1 Sample collection 
 
A. Appendiceal samples: Twenty samples were collected from 
hospitalized patients after appendectomy from different hospitals in 
Gaza strip. Collection was performed by surgeons during 
appendectomy. 
 
B. Fecal samples: Three hundreds diarrheal stools were collected from 
different hospitals (Kamal oudwan, Al-Shifa, Al-Nasser, Al-Dora, Al-
Aqsa, Nasser, Gaza-European and Al-Najar) in sterile bottles. 
 
C. Sewage samples: Twenty-six sewage samples were collected from 
six sources (a) Bietlahia WWTP, (b) El-shifa hospital, (c) Gaza 
European hospital, (d) Al-Aqsa hospital, (e) Al-Nasser hospital and (f) 
Shiek Ejleen in sterile 50 ml plastic bottles.  
D.  Animal excreta samples: Twenty-six samples were collected from 
slaughterhouses and houses using sterile bottles. 
 
E. Food samples: Fifty samples from each the following materials; meat, 
turkey, chicken, sausage, ice-cream, cheese and milk samples were 
purchased from local supermarkets and houses. 
 
F. Water samples: Two-liter samples of different water types (tap and 
well water) were collected in sterile bottles. Natural mineral water was 
purchased from a local supermarket. Tap water was obtained from 
municipal distribution system in various localities all over Gaza Strip. 
Seawater was taken at a depth of 1·5–2 m near the sewage discharge 




3.2.2 Sample transport 
 
Clinical samples were collected and transported according to the 
recommended clinical laboratory practice [5]. Environmental samples were 
collected and handled according to the protocol outlined in Standard Methods 
for Examination of Water and Wastewater (APHA) [224]. Food samples were 
collected and handled in accordance with the procedures of the FDA 
Bacteriological Analytical Manual [225]. All samples were collected in sterile 
bottles and transported in an ice box until analyzed (No more than 3 hours 
were allowed between sample collection and processing). 
3.2.3 Sample processing 
 
3.2.3.1 Preparation of sample homogenate 
 
Some of the clinical samples and environmental samples processing required 
preparation of serial dilutions, these were  cultured directly, diluted, or by 
membrane filtration, followed by incubation of the filter membrane on culture 
media [226]. 
  
A. Appendiceal samples 
Appendix samples were grinded for 2 minutes in a sterile blinder and 
transferred into 10-fold volume of TSB and incubated for 48 h at 25 °C. In 
addition, 3 ml of culture was transferred to 15 ml of thioglycollate medium. 
Homogenate were allowed to stand undisturbed at room temperature for 10 
min to allow settling of large appendix particles [227]. 
 
B. Fecal samples 
About one gram of fecal sample was placed into 10-fold volume of PBS 
[5,157]. 
 
C. Animal excreta samples  
Five-gram samples of animal excretion were homogenized with 20 ml of PBS 
[5,157]. 
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 C. Sewage samples 
Twenty five to thirty ml of the sample was inoculated into 10-fold volume of 
PBS [33,157]. 
 
D. Water samples 
Non-turbid water samples were processed using the membrane filtration 
(MF) method, 200 ml of the samples were filtered through sterile cellulose 
acetate membrane with a pore size of 0.45 (Millipore). One filter was 
aseptically placed onto the surface of selective media (CIN) agar in a 50-mm 
Petri plate which was incubated at 32°C for 48 h. The second membrane was 
aseptically placed into a bottle containing 10 ml of TSB enrichment broth and 
incubated at 25°C for 24 h. TSB enrichments were inoculated onto CIN agar 
which was incubated at 32°C for 24 h. Membrane filtration method (MF) has 
been validated for detection and enumeration of Y. enterocolitica and A. 
hydrophila from different type water [33,150]. 
 
E. Food samples 
Twenty five grams of each sample were added to 100 ml of 0.01 M PBS: pH 
7.6 and homogenized for 2 minutes in a sterile blinder. Homogenates were 
allowed to stand undisturbed at room temperature for 10 min to allow settling 
of large meat particles [77,225]. 
 
3.2.4 Isolation procedure 
 
3.2.4.1 Enrichment and plating procedures 
               
A. PBS: 0.1 ml of PBS homogenate was spread onto SS agar and incubated 
at 30°C for 24 h. 0.1 ml was spread onto CIN agar and incubated at 32°C for 
18 h. 0.1 ml was spread on MCA agar and incubated at 25oC. 0.1 ml volumes 
were spread onto Hektoen Enteric (HE) agar, and Xylose Lysine 
Deoxycholate (XLD) agar, and incubated at 32°C for 18 h. In addition, 0.5 ml 
of the PBS enrichment was removed, treated with 4.5 ml KOH, and then 
streaked onto CIN agar only [77,150].  
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B. TSB: 5 ml of PBS homogenate supernatant was transferred into 20 ml 
TSB. Incubated at 25°C for 24 h. 0.1 ml was spread onto SS agar and 
incubated at 30°C for 24 h. 0.1 ml was spread onto CIN agar, and incubated 
at 32°C for 18 h. 0.1 ml was spread on MacConkey agar and incubated the 
plates at 25oC. 0.1 ml volumes were spread onto HE, and XLD agar, and 
incubated at 32°C for 18 h. Also, 0.5 ml of the TSB enrichment was removed, 
treated with 4.5 ml KOH, and then streaked onto CIN. The TSB enrichment 
culture was re-incubated at 25°C for 2 additional days, and then was plated 
as previously described [77,150]. 
 
C. Remainder of PBS: The remainder of the PBS homogenate was 
refrigerated at 4°C and subcultured after 1,4,7 and 14 days. 0.1 ml was 
spread onto CIN agar and the plates were incubated at 32°C for 18 h. Also, 
0.5 ml of the PBS enrichment was removed, treated with KOH, and then 
streaked onto CIN. [230,231]. 
 
D. KOH treatment: 0.5 ml of enrichment culture was added to 4.5 ml 
KOH/NaCl. Vortexed briefly (3-4 sec) and immediately a loop-full of the KOH-
treated broth was streaked onto CIN agar [81]. 
 
 
3.2.4.2 Selection of colonies from plating media 
 
Due to the fact that SS, HE, XLD, MacConkey, and CIN agars are not 
completely inhibitory to non-Yersinia or Aeromonas, a variety of non-desired 
organisms may be recovered from these agars. Some of these organisms 
(e.g. strains of Morganella, Citrobacter and Enterobacter) have a colonial 
morphology similar to that of Yersinia and Aeromonas species. Care was 
exercised in the selection of suspect colonies from SS, HE, XLD, MacConkey 
and CIN agars in order to minimize picking non-Yersinia or Aeromonas.  
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A. SS: On SS, Y. enterocolitica and A. hydrophila colonies are typically round 
and opaque or colorless.  
B. HE: On HE, Y. enterocolitica and A. hydrophila colonies have a salmon 
color.  
C. XLD: On XLD, Y. enterocolitica and A. hydrophila colonies have a yellow 
color.  
D. MacConkey: On MacConkey agar the colonies were invariably smaller 
than those on the CIN agar, non lactose fermenter, flat and without entire 
margins [24,232]. 
 
E. CIN: On CIN, typical Y. enterocolitica and A. hydrophila colonies have a 
red bulls-eye which is usually very dark and sharply delineated. The bulls-eye 
is surrounded by a transparent zone with varying radii, with the edge of the 
colony either entire or irregular; colony diameter of Y. enterocolitica is 1-2 
mm but the colony of A. hydrophila is larger than Yersinia species [226,229].  
 
3.2.4.3 Identification and confirmation procedures 
 
3.2.4.3.1 Identification of Yersinia and Aeromonas 
 
A colony on CIN, HE, XLD, or SS having morphology typical of Y. 
enterocolitica or A. hydrophila was selected and streaked on blood agar 
plates for pure culture, and a colony from blood agar plates was emulsified in 
about 1 ml of sterile saline (0.85%). This was used to first inoculate a slant of 
Simmon's citrate agar, then Kligler's iron agar, and a tube of urea agar. This 
procedure was repeated with 5 colonies having morphology typical of Y. 
enterocolitica and A. hydrophila selected from each plate of selective agar 
[77,150].  
 
a. Simmon's Citrate: The slant of a tube of Simmon's citrate agar was only 
streak-inoculated, and was incubated at 28°C for 24 h. Presumptive Y. 
enterocolitica and A. hydrophila are citrate negative. 
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b. Kligler's Iron Agar: The butt was stabbed and the slant  streaked and 
was incubated at 28°C for 18-24 h. Presumptive Y. enterocolitica and A. 
hydrophila present an alkaline (red) slant and acid (yellow) butt (K/A), without 
gas or H2S in KIA. 
 
c. Christensen's urea agar:  The slant of freshly prepared urea agar slant 
was heavily streaked with the test organism and was incubated at 28°C for 
24-72 h. Presumptive Y. enterocolitica is (+) for urease and will turn the agar 
to an intense red-pink color while A. hydrophila is (-). 
 
3.2.4.3.2 Confirmation of Yersinia enterocolitica and Aeromonas 
hydrophila 
 
One well-isolated colony from each culture was used to inoculate 5 ml of 
0.85% NaCl medium, pH 5.5 to 7.0. A humid atmosphere was provided, and, 
to identify the organisms, commercially available bacterial identification kit, 
API 20E test, a kit (Biomerieux, France) was used according to the 
instructions of the manufacturer. After 18 to 24 h, all reactions were analyzed 
according to the interpretation chart included in the package insert. Reagents 
were added to the TDA, Voges-Proskauer, and IND tubes, and the reactions 
were recorded. Inoculum for further testing was obtained from the KIA slant 
[77,150].  
 
For additional speciation of Yersinia and Aeromonas, the following tests were 
performed: 
 
A. Oxidase test: A colony growing on KIA slant of any presumptive Y. 
enterocolitica and A. hydrophila isolates was tested for oxidase by the 
commercially available reagent-impregnated test discs. Yersinia is oxidase 
negative (-) while A. hydrophila is oxidase (+) [77,150]. 
 
B. Deoxyribonuclease (DNase) test: Yersinia and Aeromonas strains were 
inoculated onto a plate of DNase test agar by streaking the medium in a band 
( about 1.9 cm length streak). Plates were incubated at 28°C for 18-24 h. 
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Following incubation, plates were examined as follows: Plate was flooded 
with 1 N HCl. A zone of clearing around a colony indicates a positive test. 
Yersinia and Aeromonas strains are DNase (+) [77,150]. 
 
3.2.4.4 Testing for pathogenicity markers 
 
A. Pyrazinamidase test: Isolates were inoculated over entire slant of 
pyrazinamide agar and incubated at 25°C for 48 h. Slant surface were 
flooded with 1 ml of freshly prepared 1% (w/v) aqueous solution of Ferric 
ammonium sulfate. Test results were read after 15 min; a pink to brown color 
indicates PYZ positive (+), (presence of pyrazinoic acid) while no color 
development is observed with PYR negative (-) strains. Pathogenic strains of 
Yersinia are PYZ negative and A. hydrophila are PYZ positive [10,129,191]. 
 
B. Esculin hydrolysis: A plate of esculin agar was inoculated with the test 
strain. The plate was incubated at 25°C for 10 days, reading after 1,2,3,7 and 
10 days. Blackening indicates esculin hydrolysis. Pathogenic Y. enterocolitica 
is negative for this test while A. hydrophila is esculin positive [10,129,233]. 
 
C. Auto-agglutination in MR-VP and BHI broth: Individual isolates were 
evaluated for the ability to autoagglutinate in MR-VP broth for Y. 
enterocolitica and brain heart infusion broth (BHIB) for A. hydrophila as 
follows. For Y. enterocolitica; 2 tubes of MR-VP broth were inoculated; one 
was incubated at 25°C for 24 h, and the other at 35°C for 24 h. After 18 to 24 
h incubation, the tubes were observed for agglutination, with care taken not 
to shake or disturb the sediment at the bottom and along the sides of the 
tube. The tube incubated at the lower temperature should exhibit turbidity 
from cell growth. The tube which had been incubated at 35°C should show 
agglutination (clumping) of bacteria along the walls and/or bottom of tube and 
clear supernatant fluid. Virulence plasmid agglutinates at 35°C but not 25°C. 
Isolates that lack the virulence plasmid do not agglutinate at either 
temperature [10].  
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The autoagglutination test for selfpelleting (SP+) and precipitation after 
boiling (PAB+) phenotype characterization was carried out as described by 
Janda et al.,. Each A. hydrophila isolate  was grown in 6 ml of BHIB for 18 h 
at 28°C. At the end of the incubation period, cultures were observed for 
evidence of self-pelleting, which was manifested as a large aggregate of cells 
at the bottom of the tube and the absence of turbidity in the medium. A 3-ml 
fraction was heated for 1 h at 100°C in a water bath and then cooled for 10 
min and compared with the samples kept at room temperature for a control. 
Reduction in turbidity was considered positive for precipitation after boiling 
[164,233]. Both pathogenic Y. enterocolitica and A. hydrophila are positive 
for this test. 
 
D. Crystal violet binding test: This rapid screening test differentiates 
potentially virulent Y. enterocolitica and A. hydrophila cultures. Suspected 
cultures were grown for 18 h at 22-26°C in BHI broth with shaking. Each 
culture was diluted in physiological saline. 0.1 ml of each culture was spread 
to each of two BHI agar plates. The plates were incubated at 25°C or 37°C 
for 30 h. Each plate was gently flooded with 8 ml of 85 µg/ml of crystal violet 
(CV) solution for Y. enterocolitica and 0.5 mg/ml for A. hydrophila for 2 min 
and the crystal violet uptake was qualitatively determined. Colonies were 
observed for their CV binding.  The binding of CV to positive colonies was 
observed by their dark violet appearance, while negative colonies failed to 
bind the dye and remained white.  Photographs of colonies were made for 
permanent records [10,234]. 
 
E. Beta haemolysin production of A. hydrophila: Haemolytic activity of the 
organisms studied was detected on blood agar plates containing 5% human 
blood. All tests were incubated in air at 37°C for 18-24 h. Isolates exhibiting 
hemolytic zones in excess of 2 mm from the streak inoculum were 
considered positive [137]. 
 
Yersinia and Aeromonas isolates were stored in TSB with 20% (v ⁄ v) glycerol 
at -80oC until further testing. 
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3.2.4.5 Antimicrobial susceptibility testing 
All Y. enterocolitica and A. hydrophila isolates were tested for antimicrobial 
susceptibility using disk diffusion method using Mueller Hinton agar and 
antibiotic disks procured from Hi-Media laboratories, India, according to 
National Committee for Clinical Laboratory Standard (NCCLS). 3-5 colonies 
of each isolate were introduced into a tube containing BHIB. These tubes 
were incubated for 4-6 h and the broth culture turbidity was adjusted to that 
of 0.5 McFarland standard. Muller Hinton plates were dried for a bout 30 min 
before inoculation and were used within one day of preparation. The 
standardized bacterial broth suspension was streaked on the surface of the 
medium with a cotton swab. After the inoculum had dried (3-5 min) the disks 
were placed on the agar with flamed forceps and gently pressed down to 
ensure contact [235].  
The plates were incubated for 24 h at 37oC and the diameter of zone of 
inhibition of each antimicrobial agent was compared with the chart supplied 
by the manufacturer and interpreted as sensitive, intermediate or resistant. 
The following table includes the list of antimicrobials and their potencies used 
for the antimicrobial testing. 
Table (3.1): Antimicrobial disks used in the susceptibility testing of Y. 
enterocolitica and A. hydrophila  
Antimicrobial agents Abbreviation Disk potency 
Amikacin Ak 30 µg 
Ampicillin A 10 µg 
Amoxycillin-Clavulanate AC 30 µg 
Aztreonam Ao 30 µg 
Cephalexin Cp 30 µg 
Cefazolin Cz 30 µg 
Cefotaxime Ce 30 µg 
Ceftazidim Ca 30 µg 
Ceftriaxone Ci 30 µg 
Cefuroxime Cu 30 µg 
Ciprofloxacin Cf 5 µg 
Chloramphenicol C 30 µg 
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Doxocycline Do 30 µg 
Erythromycin E 10 µg 
Gentamicin G 10 µg 
Meropenem MEM 10 µg 
Nalidixic acid Na 30 µg 
Ofloxacin Ofx 5 µg 
Co-trimethoprim Co 25 µg 
Tetracycline Te 30 µg 
 
3.3 Permission and Ethics 
 
Permission was taken from Helsinki Committee, Hospitals General 
Administration, patients or patients guardians and workers in GWWTP and 




 The questionnaire used in this study included open and closed questions 
and data collected by interviewing  patients or patients guardians to record 
address, age, sex, date of onset of illness and duration of illness. A checklist 
inquired about symptoms, including the presence of diarrhea, number of 
stools per day, consistency of stools, presence of blood or mucous, 
occurrence of abdominal pain or cramping, presence of  vomiting, and fever. 
Epidemiological questions explored exposure to animals. Respondents were 
asked to specify the use of an untreated private or treated public drinking 
water supply. A cover letter accompanied each questionnaire explaining the 
purpose of the study. Questionnaires were tabulated to determine age and 
sex correlation with gastrointestinal disease, characteristic symptoms, and 
possible exposures and predisposing factors necessary to establish infection.  
 
 [[[[ 
3.5 Data analysis 
 
Data obtained from microbiological investigation and from the questionnaire   
survey  were uploaded   to (SPSS version 15) software and analyzed using 






This study was conducted on 300 patients to investigate the presence of Y. 
enterocolitica and A. hydrophila in clinical samples. 95 food samples and 84 
environmental samples were also tested. All suspected Y. enterocolitica and A. 
hydrophila were identified using conventional microbiological techniques. 
 
4.1 Identification of Yersinia enterocolitica and Aeromonas hydrophila 
 
All suspected Y. enterocolitica and A. hydrophila were presumptively identified 
using colonial morphology and by the use of (urea agar, Simmon's citrate agar 
and Kligler's iron agar). All cultures of Y. enterocolitica were positive for urease 
while A. hydrophila were negative and all of Y. enterocolitica and A. hydrophila 
were negative for citrate utilization. On Kligler's iron agar after both pathogens 










Table 4.1 indicates the biochemical reaction of Y. enterocolitica and A. 
hydrophila isolated from clinical, food and environmental samples.  
 
Table (4.1): Biochemical profiles and other properties of Y. enterocolitica and A. 
hydrophila isolated from different sources 
 
 







Arginine dihydrolase (ADH) - + 
Lysine decarboxylase (LDC) - - 
Ornithine decarboxylase (ODC) + - 
Citrate utilization - - 
H2S production - - 
Urease production + - 
Tryptophane deaminase (TDA) - - 
Indole production + + 
Voges- Proskauer + + 
Gelatinase production - + 
D-Glucose + + 
D-Mannitol + - 
Inositol +/- - 
D-Sorbitol +/- - 
L-Rhamnose - - 
D-Sucrose +/- + 
D-Melibiose -/+ - 
amygdalin + + 





Presumptive Yersinia and Aeromonas were identified biochemically by API 20E 
system (Figure 4.2). 
 




Figure (4.2): API 20E reactions for (A) Y. enterocolitica and (B) A. hydrophila 
 
All cultures of Y. enterocolitica and A. hydrophila grown on CIN agar plates were 
gram and wayson stained and showed negative reaction with rod to coccobacilli 
morphology with bipolar staining: All cultures of Y. enterocolitica were negative 
for oxidase, gelatin hydrolysis, lysine decarboxylase, arginine dihydrolase 
(ADH), and phenylalanine deaminase. On the other hand, all cultures of A. 
hydrophila were positive for oxidase and ADH. The results of the remaining tests 




4.2 Distribution of Yersinia and Aeromonas isolates 
 
Yersinia species were isolated from all sampled sources. The highest incidence 
was from sewage (19.1%) followed by animal excreta (11.5%), while, clinical 
samples showed the lowest percentage (4.7%). With regard to A. hydrophila, 
meat and water showed the highest incidence (48.9% and 46.9% respectively). 
The overall frequency of Yersinia and Aeromonas isolates was 6.3% and 38.1% 
respectively (Table 4.2). 
 




Sample type No. 
No. % No. % 
Clinical samples 300 14 4.7 103 34.3 
Animal excreta 26 3 11.5 10 38.5 
Meat 45 3 6.7 22 48.9 
Milk 50 3 6 18 36 
Sewage 26 5 19.1 11 42.3 
Water 32 2 6.25 15 46.9 
Total 473 30 6.3 179 38.1 
 
 
4.3 Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
clinical samples 
 
Cultures of Y. enterocolitica and A. hydrophila were performed on 300 diarrheic 
stool samples and 20 appendiceal samples after appendectomy. The median 
age of the patient population was 3.6 years (range 40 days to 47 years), and 
55% were males (Table 4.3 and Figure 4.3). 
 67
 
Table (4.3): Age distribution of the study sample 
 
Age group Frequency Percent 
Below 2 years 126 42  
2 - less than 6 years 132 44 
6 - less than 15 years 28 9.3 
Over 15 14 4.7 






Figure (4.3): Sex distribution of the study population 
 
One hundred fifty eight stool samples were collected from patients below the 
age of 6 and only 14 samples from patients older than 15 years. From table 4.4, 
it could be observed that both Yersinia and Aeromonas were isolated with a 
higher frequency from patients belonging to the age group 2 to less than 6 years 
(2.3% and 20.3% respectively). There was a decline in incidence of both 
pathogens with increasing age. A significant association was found among Y. 










No. % No. % 
Below 2 years 5 1.7 31 10.3 
2- less than 6 years 7 2.3 61 20.3 
6- less than 15 years 1 0.3 8 2.7 
Over 15 1 0.3 3 1.0 
Total 14 4.7 103 34.3 
P: 0.001  
 
A total of 14 (4.7%) Y. enterocolitica and 103 (34.3 %) A. hydrophila isolates 
were recovered from 300 patients with acute diarrhea, whereas no isolates were 
recovered from appendiceal samples. Other bacterial enteropathogens were 
isolated from 300 patients with diarrhea; 3 isolates (1.0%) of Salmonella spp. 














Figure (4.4): Frequency and distribution of Y. enterocolitica and A. hydrophila 
and other enteropathogens in clinical samples 
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4.3.1 Detection of Yersinia enterocolitica and Aeromonas hydrophila from 
different hospitals 
 
Clinical samples were collected from eight hospitals located in various parts of 
Gaza strip. Y. enterocolitica was detected in 5 hospitals with high incidence at 
Al-Dorrah hospital. On the other hand, A. hydrophila was detected in all 
hospitals with the highest frequency from Al-Nasser hospital (Table 4.5). A 
significant association was found between the number of isolates and source of 
clinical samples (P<0.05). 
 
Table (4.5): Distribution of Yersinia and Aeromonas according to hospital 
 
Yersinia Aeromonas 
Hospital Location No. % 
No % No % 
AL-Aqsa Deir-Albalah 101 33.7 4 4.0 41 40.6 
Al-Nasser Gaza 47 15.7 3 6.4 21 44.6 
Al-Shifa Gaza 32 10.7 0 0.0 4 12.5 
Al-Najar Rafah 30 10.0 2 6.7 8 26.6 
Gaza-European Rafah 23 7.7 0 0.0 5 21.7 
Kamal-odwan Bit-lahia 15 5.0 0 0.0 4 26.7 
Nasser Khan-Younes 36 12.0 2 5.6 13 36.1 
Al-Dorrah Gaza 16 5.3 3 21.4 7 43.8 
Total 300  100.0 14 4.7 103 34.3
P = 0.001 
 
4.3.2 Associated clinical features  
 
All patients with Y. enterocolitica had watery diarrhea ranged from 3 to 7 days in 
duration. The frequency of defecations ranged from 3 to 7 daily.  Most (92.2%) 
of the patients had vomiting, mucus and fever >39 oC. Other symptoms included 
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blood in stool (64.3%) and abdominal pain (28.6%). All patients with A. 
hydrophila had watery diarrhea of 3 to 7 days in duration. The maximum 
frequency of defecation was over 7 daily (95.1%).  66 % of the patients had 
vomiting and 77.7 % of the patients had fever > 39oC. Additional symptoms 
included, blood in the stool (43.7%), mucus (67%), and abdominal pain (26.2%), 
with significant association for both pathogens between the isolates and 
frequency of defecation (p< 0.05) (Table 4.6). 
 
  Table (4.6): Clinical features of 14 patients with Y. enterocolitica and 103 
with A. hydrophila diarrhea 
 
  
No. of positive isolates (%) 
Clinical features 
Y. enterocolitica   A. hydrophila 
 
3-7 daily 14 (100)  5 (4.9) Frequency of 
defecation >7 daily 0 (0.0)  98 (95.1) 
<39oC 1 (7.1)  23 (22.5) Fever 
>39oC 13 (92.2)  80(77.7) 
Yes 13 (92.2)  68(66.0) Vomiting 
No 1 (7.1)  35 (34.0) 
Yes 13 (92.2)  69 (67.0) Mucus 
No 1 (7.1)  34 (33.0) 
Duration  3-7 days 14 (100)  103(100) 
Yes 9 (64.3)  45 (43.7) Bloody stool 
No 5 (35.7)  58(56.3) 
Yes 4 (28.6)  27 (26.2) Abdominal pain 




4.4 Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
food samples 
 
4.4.1 Milk and milk product samples 
 
Fifty dairy product samples were collected from different places in Gaza strip. Of 
the 50 different milk samples analyzed, 3 displayed the presence of Y. 











Figure (4.5): Frequency and distribution of Y. enterocolitica and A. hydrophila in 
milk and milk product samples 
 
  
Y. enterocolitica was isolated only from cow milk (3 isolates, 16.7%), and the 
occurrence of A. hydrophila was slightly higher in cheese (75%) than in goat 
milk (66.7) and cow milk (22.2%). There was a significant relationship between 

















Yersinia Aeromonas Shigella Negative 
NO. 3 4 2 9 Cow milk 18 36.0 
%  16.7 22.2 11.1 49.9 
NO. 0 4 0 2 Goat milk 6 12.0 
%  0.0 66.7 0.0 33.3 
NO. 0 0 0 5 Pasteurized 
milk 5 10.0 %  0.0 0.0 0.0 100 
NO. 0 0 0 2 Powdered 
milk 2 4.0 %  0.0 0.0 0.0 100 
NO. 0 7 0 8 Ice cream 15 30.0 
%  0.0 46.7 0.0 53.3 
NO. 0 3 0 1 
Cheese 4 8.0 
%  0.0 75.0 0.0 25.0 
NO. 3 18 2 27 Total 
 50 100 %  6.0 36.0 4.0 54.0 
P = 0.002 
 
 
4.4.2 Meat samples 
 
 
A total of 3 (6.7%) Y. enterocolitica isolates from different food samples were 
obtained from 45 food samples. One Y. enterocolitica was isolated from 20 cow 
samples (33.3%) and 2 isolates from 7 turkey samples, with no additional 
isolates from sausage, hamburger, chicken and packed meat samples. On the 
other hand, 22 A. hydrophila  isolates were recovered from the same food 
samples.  One A. hydrophila was isolated from 6 chicken samples, 7 from 20 
cow samples, 5 from 5 hamburger samples, 2 from 2 packed samples, 2 from 7 
turkey samples and 5 from 5 sausage samples. We were able to isolate two 
Salmonella species from these samples. These rates of isolation of pathogenic 





















Figure (4.6): Frequency and distribution of tested food samples  
 
Table (4.8): Number and percent of Y. enterocolitica and A. hydrophila 
recovered from various meat samples 
 





%  Yersinia Aeromonas Salmonella Negative
NO. 0 1 0 5 Chicken  6 13.3 
% 0.0 16. 7 0.0 83.3 
NO. 1 7 0 12 Cow   20 44.4 
% 5.0 35 0.0 60.0 
NO. 0 5 0 0 Hamburger 5 11.1 
% 0.0 100 0.0 0.0 
NO. 0 2 0 0 Packed  2 4.4 
% 0.0 100 0.0 0.0 
NO. 2 2 2 1 Turkey 7 15.6 
% 28.6 28.6 28.6 14.3 
NO. 0 5 0 0 Sausage 5 11.1 
% 0.0 100 0.0 0.0 
NO. 3 22 2 18 Total 45 100 
% 6. 7 48. 9 4.4 40.0 
P = 0.001 
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4.5 Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
environmental samples  
 
4.5.1 Water samples 
 
Figure 4.7 shows the distribution of Y. enterocolitica and A. hydrophila in 
different types of tested water. A total of 2 isolates of Y. enterocolitica were 
recovered from a total of 32 water samples, one from tap water and the other 
from well water with no isolate from sea water. On the other hand, 15 isolates of 
A. hydrophila were recovered from different types of water, 2 isolates from sea 
water, 6 isolates from tap water and 7 isolates from well water were obtained;  
with higher incidence of both organisms in tap and well water. There was a 
















Table (4.9): Number and percentage of Y. enterocolitica and A. hydrophila 




 No. %   Yersinia Aeromonas Negative 
NO. 0 2 3 Sea water 
  
5 15.6 
% 0.0 40 60.0 
NO. 1 6 6 Tap water 13 40.6 
% 7.7 46.2 46.2 
NO. 1 7 6 
Wells water 14 43.8 
% 7.1 50.0 42.9 
NO. 
2 15 15 Total 32 100 
%  6.25 46.9 46.9 
P = 0.004 
  
4.5.2 Sewage samples 
 
Five Yersinia spp. were recovered from 26 sewage samples. Y. enterocolitica 
was the most frequently isolated Yersinia spp. It was found in 3 (11.5%) of 26 
samples. The other two isolates were identified as Yersinia kristensenii (7.7%). 













Figure (4.8): Y. enterocolitica and A. hydrophila isolated from sewage samples    
 76
4.5.2.1 Regional distribution of Yersinia enterocolitica and Aeromonas 
hydrophila isolated from sewage samples 
 
A total of 26 sewage samples were collected from 6 different sampling points.  
From the 26 sewage samples, 11 (42.3%) A. hydrophila, 3 (11.5%) Y. 
enterocolitica and two environmental Yersinia kristensenii were isolated.  The 
high incidence of Y. enterocolitica and A. hydrophila were from Al-Nasser 
hospital, 33.3% and 66.7% respectively, with no significant relationship between  
the number of isolates and source of sewage samples (p >0.05) (Table 4.10).                           
 
Table (4.10): Number and percentage of Yersinia and Aeromonas isolated from 
each sampling points 
  
 Sewage Isolates  







NO. 0 2 1 1 Bit-lahia 
WWTP 4 
 
15.4 %  0.0 50.0 25.0 25.0 
NO. 0 2 0 0 European 
Hospital 4 15.4 %  0.0 50.0 0.0 0.0 
NO. 1 2 0 2 Al-Nasser 
Hospital 3 11.5 %  33.3 66.7 0.0 66.7 
NO. 0 1 0 2 El-shifa 
Hospital 3 11.5 %  0.0 33.3 0.0 66.7 
NO. 1 2 1 4 Al-aqsa 
Hospital 8 30.8 %  12.5 25.0 12.5 50.0 
NO. 1 2 0 1 Shiek Ejleen 
WWTP 4 15.4 %  25.0 50.0 0.0 25.0 
NO. 3 11 2 10 Total 26 100 
%  11.5 42.3 7.7 38.5 
 
4.5.3. Animal excreta samples 
 
Fecal specimens were collected from different animals of Gaza strip. A total of 3 
(11.5%) Y. enterocolitica and 10 (38.5%) A. hydrophila were isolated from 26 
animal excreta samples (Figure 4.9). Other enteropathogens; Salmonella 












Figure (4.9): Frequency of Y. enterocolitica and A. hydrophila isolated from 
animal excreta samples  
 
Twenty-six animal excreta samples were collected from different sources, 4 
(15.4%) from chickens, 7 (26.9%) from cows, 8 (30.8%) from goats, and 7 
(26.9%) from turkeys. The maximum number of Y. enterocolitica was recovered 
from cow's excreta (28.6%) and A. hydrophila from goat's excreta (62.5%) 
(Table 4.11). There is no statistically significant differences between occurrence 
of both pathogens and type of animal excreta (P > 0.05). 
 
Table (4.11): The number and percentage of Y. enterocolitica and A. hydrophila 
isolated from animal excreta samples. 
 
Animal excreta Isolates 
 







NO. 0 0 0 4 Chicken 4 15.4 
% 0.0 0.0 0.0 100 
NO. 2 3 1 1 Cow 7 26.9 
% 28.6 42.9 14.3 14.3 
NO. 0 5 0 3 Goat 8 30.8 
% 0.0 62.5 0.0 37.5 
NO. 1 2 1 3 Turkey 7 26.9 
% 14.3 28.6 14.3 42.9 
NO. 3 10 2 11 Total 
 26 100 % 11.5 38.5 7.7 42.3 
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4.6 Isolation of Yersinia enterocolitica and Aeromonas hydrophila using 
different enteric agar media 
 
In this study, SS, HE, XLD, MCA and CIN agars were used to isolate Y. 
enterocolitica and A. hydrophila. The ability of enteric media to selectively 
support the growth of Y. enterocolitica and A. hydrophila was evaluated using 
clinical and food samples. Figures 4.10 (A,B,C,D) show the colony morphology 
of Y. enterocolitica and A. hydrophila on SS, HE, XLD and CIN agars 
respectively after incubation at 32°C for 24 h.  
 




Figure (4.10.A): Appearance of Y. enterocolitica (A) and A. hydrophila (B) on 





B: On HE agar: Both Y. enterocolitica and A. hydrophila showed salmon color 




Figure (4.10.B): Appearance of Y. enterocolitica (A) and A. hydrophila (B) on 
HE agar after 24 h of incubation at 32°C. 
 
C: On XLD agar: Y. enterocolitica and A. hydrophila appeared yellow color.  
 
 
Figure (4.10.C): Appearance of Y. enterocolitica (A) and A. hydrophila (B) on 




 D: On CIN agar: Y. enterocolitica and A. hydrophila appeared deep red center 




Figure (4.10.D): Appearance of Y. enterocolitica (A) and A. hydrophila (B) on 




4.6.1 Evaluation of the efficacy of selective media for the recovery of 
Yersinia enterocolitica and Aeromonas hydrophila from clinical and food 
samples 
 
For the sake of comparison, CIN agar was considered as the golden standard 
for the isolation of both Y. enterocolitica and A. hydrophila. The results in table 
4.12 clearly show different recovery efficacy for SS, HE, XLD and CIN agars in 
isolating Y. enterocolitica and A. hydrophila. However all three selective media 
showed inferior recovery when compared to CIN. They were even more inferior 
than CIN when dealing with food and environmental samples.  
 
Table (4.12): Number and percentage of Y. enterocolitica and A. hydrophila 
using different culture method 
 
aSS, Salmonella Shigella agar, bHE, Hektoen enteric agar 
cXLD, Xylose Lysine Dextrose agar, dCIN, Cefsulodin-Irgasan-Novobiocin agar 
P value= 0.000 
  Clinical Isolates Meat isolates 
Media 
  Yersinia N= (14 ) 
Aeromonas 





NO. 1 4 0 0 Growth
% 7.1 3.9 0.0 0.0 
NO. 13 99 3 22 
SSa 
No growth 
% 92.9 96.1 100 100 
NO. 1 3 0 0 Growth
% 7.1 2.9 0.0 0.0 
NO. 13 100 3 22 
HEb
No growth
% 92.9 88.5 100 100 
NO. 1 3 0 0 Growth
% 7.1 2.9 0.0 0.0 
NO. 13 100 3 22 
XLDc
No growth
% 92.9 88.5 100 100 
NO. 14 103 3 22 Growth
% 100 100 100 100 
NO. 0 0 0 0 
CINd No growth
% 0.0 0.0 0.0 0.0 
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4.6.2 Efficacy of KOH treatment 
 
Three methods were used to detect Y. enterocolitica and A. hydrophila from 
clinical, food and environmental samples. The three methods were; direct plating  
on CIN agar after KOH treatment, cold enrichment in PBS followed by plating on 
CIN agar and overnight enrichment in TSB followed by plating on CIN agar. 
Yersinia and Aeromonas organisms are more tolerant to alkali conditions than 
are most other bacteria, and enrichment cultures may be exposed to KOH to 
selectively reduce the level of competing microorganisms. All Yersinia and 
Aeromonas isolates in clinical and food samples were detected in large numbers 
on CIN agar on primary isolation, after treatment with KOH. No additional 
isolates were detected following cold enrichment in PBS and following overnight 
enrichment in TSB.  
 
The percent recovery of Yersinia and Aeromonas using the KOH method was 
100% as compared with 78.6%, 66.7% recovery for Y. enterocolitica and 76.7%, 
77.3% for A. hydrophila  after 14 days of incubation in PBS at 4oC from clinical 
and food samples respectively. On the other hand, 100%, 66.7% recovery for Y. 
enterocolitica and 94.2%, 86.4% for A. hydrophila by TSB after 48 hr incubation 
from clinical and food samples respectively (Table 4.13). Direct plating on CIN 
agar after treatment with KOH was significantly (p <0.000) more sensitive than 
cold enrichment in PBS and overnight enrichment in TSB.  
 
Figure 4.11 illustrates a CIN agar plate after 24 h of incubation at 25oC. One-half 
of the plate was streaked with alkali-treated inoculum, the other half with saline-
treated inoculum. Many small, distinct, bulls eyes red colonies characteristic of 
Yersinia and Aeromonas were seen on the alkali treated inoculum; numerous 
large, pigmented, mucous colonies characteristic of non-Yersinia and 
Aeromonas colonies were seen on the saline-treated inoculum. 
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Table (4.13): Number and percentage of Yersinia and Aeromonas isolates from  
patient stools according to isolation technique 
aKOH, Direct plating on CIN agar with Potassium hydroxide, bPBS 
 Cold enrichment in phosphate buffered saline for 2 weeks 
 cTSB, Overnight enrichment in TSB 




Figure (4.11): CIN agar plate after 24h of incubation at 26°C, streaked with Y. 
enterocolitica treated with saline (top section) and alkali (bottom section) 
    Clinical Isolates  Meat isolates Enrichment 
techniques  Yersinia  







NO. 14 103 3 22 Growth 
% 100 100 100 100 
NO. 0 0 0 0 
KOHa 
No 
growth % 0.0 0.0 0.0 0.0 
NO. 11 79 2 17 Growth 
% 78.6 76.7 66.7 77.3 




growth % 21.4 23.3 33.3 22.7 
NO. 14 97 2 19 Growth 
% 100 94.2 66.7 86.4 
NO. 0 6 1 3 
TSBc
No 
growth % 0.0 5.8 33.3 13.6 
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4.7 Virulence factors of Yersinia enterocolitica and Aeromonas hydrophila  
 
Pyrazinamidase production, esculin hydrolysis, autoagglutination and crystal 
violet binding assay were tested in 28 Y. enterocolitica and 180 A. hydrophila 
isolates from various origins. Beta hemolysin production was tested on A. 
hydrophila isolates only. Pathogenic isolates of Y. enterocolitica are 
pyrazinamidase and esculin hydrolysis negative but positive for 
autoagglutination and crystal violet binding assay, while pathogenic A. 
hydrophila are positive for all virulence factors including beta hemolysin 
production. According to the results of this virulence factors, the highest 
percentage for the pathogenic strains of Y. enterocolitica (64.3%) and A. 
hydrophila (92.2%) was recovered from clinical samples, while environmental 
isolates showed virulence characteristics in some of these tests. Using the Chi 
square test, differences were significant for all tests in clinical samples (P < 
0.05) whereas the difference was not significant (P > 0.05) with the 
environmental samples isolates. 
 
In sewage samples, the two Y. kristensenii isolates were positive for 
Pyrazinamidase activity and esculin hydrolysis but negative for autoagglutination 
and crystal violet binding. Tables (4.14-4.17) present the virulence 
characteristics for Y. enterocolitica and A. hydrophila. 
 
A.  Pyrazinamidase production: Pyrazinamidase activity in Y. enterocolitica 
and A. hydrophila from clinical and environmental samples were reported in 
Table 4.14. Of the 14 clinical Y. enterocolitica isolates tested, 5 isolates (64.3%), 
2 meat isolates (33.3%), 2 milk isolates (33.3%), 1  water isolates (50%), 2 
sewage isolates (33.3%) and 2 animal excreta isolates (33.3%) were negative. 
On the other hand of A. hydrophila, 95 Aeromonas clinical isolates (92.2%), 4 
meat isolates (18.8%), 6 milk isolates (33.3%), 5 water isolates (33.3%), 4 
sewage isolates (36.4%) and 4 animal excreta isolates (40%) were positive.  
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Table (4.14): Pyrazinamidase production in relation to the source of Y. 
enterocolitica and A. hydrophila 
 








Clinical samples 300 14 5 64.3 103 95 92.2
Meat samples 45 3 2 33.3 22 4 18.8
Milk samples 50 3 2 33.3 18 6 33.3
Water samples 32 2 1 50 15 5 33.3
Sewage samples 26 3 2 33.3 11 4 36.4
Animal excreta samples 26 3 2 33.3 10 4 40 
 
 
B.  Esculin hydrolysis: With esculin hydrolysis, 5 of 14  Yersinia clinical 
isolates (64.3%), 2 of 3 meat isolates (33.3%), 2 of 3 milk isolates (33.3%), 1 of 
2 water isolates (50%), 2 of 3 sewage isolates (33.3%) and 2 of 3 animal excreta 
isolates (33.3%) were negative. On the other hand,  95 of 103  Aeromonas 
clinical isolates (92.2%), 14 of 22 meat isolates (66.7%), 10 of 18 milk isolates 
(55.6%), 8 of 15 water isolates (53.3%), 8 of 11 sewage isolates (72.7%) and 6 
of 10 animal excreta isolates (60%) were positive (Table 4.15, Figure 4.12).  
 
Table (4.15): Esculin hydrolysis in relation to the source of Y. enterocolitica and 
A. hydrophila 
 









Clinical samples 300 14 5 64.3 103 95 92.2
Meat samples 45 3 2 33.3 22 14 66.7
Milk samples 50 3 2 33.3 18 10 55.6
Water samples 32 2 1 50 15 8 53.3
Sewage samples 26 3 2 33.3 11 8 72.7
Animal excreta samples 26 3 2 33.3 10 6 60 
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Figure (4.12): Esculin hydrolysis by Y. enterocolitica and A. hydrophila 
 
 
C.  Autoagglutination: Table 4.16 and Figure 4.13 show the pattern of 
autoagglutination for clinical and environmental isolates. Of Yersinia isolates, 9 
(64.3%) of clinical isolates, 1 (33.3%) of meat isolates, 1 (33.3%) of milk 
isolates, 1 (50%) of water isolates, 1 (33.3%) of sewage isolates and 1 (33.3%) 
of animal excreta isolates were positive for autoagglutination. On the other hand, 
95 (92.2%) of Aeromonas clinical isolates, 9 (40.9%) of meat isolates, 6 (33.3%) 
of milk isolates, 5 (33.3%) of water isolates, 4 (36.4%) of sewage isolates and 4 
(40%) of animal excreta isolates were positive. 
 
Table (4.16): Autoagglutination in relation to the source of Y. enterocolitica and 
A. hydrophila 
 Y. enterocolitica A. hydrophila 
Positive Positive Samples  
N N N % 
N 
N % 
Clinical samples 300 14 9 64.3 103 95 92.2 
Meat samples 45 3 1 33.3 22 9 40.9 
Milk samples 50 3 1 33.3 18 6 33.3 
Water samples 32 2 1 50 15 5 33.3 
Sewage samples 26 5 1 33.3 11 4 36.4 
Animal excreta samples 26 3 1 33.3 10 4 40 
  




Figure (4.13): Appearance of autoagglutination phenomenon after 18 h of 
growth in MR-VR broth at 35°C. Positive test (left) and negative test (right). 
 
D. Crystal violet binding: With crystal violet binding, of Y. enterocolitica 
isolates tested, 9 (64.3%) of clinical isolates, 1 (33.3%) of meat isolates, 1 
(33.3%) of milk isolates, 1 (50%) of water isolates, 1 (33.3%) of sewage isolates 
and 1 (33.3%) of animal excreta isolates were positive for crystal violet binding. 
On the other hand, , 95 (92.2%) of A. hydrophila clinical isolates, 9 (40.9%) of 
meat isolates, 6 (33.3%) of milk isolates, 5 (33.3%) of water isolates, 4 (36.4%) 
of sewage isolates and 4 (40%) of animal excreta isolates were positive (Table 
4.17, Figure 4.14). 
 
Table (4.17): Crystal violet binding in relation to the source of Y. enterocolitica  
and A. hydrophila 
 
 




N N N % 
N 
N % 
Clinical samples 300 14 9 64.3 103 95 92.2 
Meat samples 45 3 1 33.3 22 9 40.9 
Milk samples 50 3 1 33.3 18 6 33.3 
Water samples 32 2 1 50 15 5 33.3 
Sewage samples 26 5 1 33.3 11 4 36.4 
Animal excreta samples 26 3 1 33.3 10 4 40 
L  R 
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In this investigation, both environmental and clinical isolates were capable of 
producing virulence factors to various degrees. Y. enterocolitica and A. 
hydrophila isolates from the clinical samples proved the most virulent as judged 
by possession of all four virulence-associated factors. 
 
E. Beta hemolytic activity of Aeromonas hydrophila as a virulence factor 
Most of the isolates were beta-hemolytic when assayed on blood agar plates 







Figure (4.15): Frequency of β- hemolytic activity of A. hydrophila 
 
 
Figure (4.14): Positive (A) and negative (B) crystal violet binding of Y. 




Figure (4.16): β- hemolytic activity of A. hydrophila on blood agar plate 
 
4.8 Susceptibility of Yersinia enterocolitica and Aeromonas hydrophila to 
various antimicrobial agents 
 
In this test, all clinical Yersinia (14) isolates were resistant to 
amoxycillin/clavulanate, cefazolin and erythromycin.   In contrast, all of the 
isolates were susceptible to co-trimoxazole, amikacin, gentamicin and 
cefotaxime. In addition, 90% or more of the isolates examined in this study were 
susceptible to aztreonam, ciprofloxacin, ofloxacin, ceftriaxone, and meropenem. 
Environmental Y. enterocolitica (14) isolates during the same periods displayed 
susceptibility patterns similar to those of the human isolates (Table 4.18). All of 
these isolates were not susceptible to cefazolin and erythromycin. With regard to 
the other antimicrobials agents (ampicillin cephalexin, ceftriaxone, ciprofloxacin, 
ofloxacin, and aztreonam), the susceptibility results were variable (Figure 4.17 





Figure (4.17): Antibiotic Susceptibility of Y. enterocolitica  
 
All 103 clinical A. hydrophila isolates were resistant to ampicillin,  
amoxycillin/clavulanate, cefazolin, cephalexine, co-trimethoprim and 
erythromycin. In contrast, Most of the isolates were susceptible to the third 
generation of cephalosporins, Cefotaxime. Also, most of the isolates were 
susceptible to amikacin, aztreonam, ciprofloxacin and ofloxacin. The 
environmental isolates (84) included in this study showed the same or slightly or 
the same resistance compared to clinical isolates. All environmental isolates 
were resistant to ampicillin, amoxycillin/clavulanate, cephalexine, cefazolin, co-
trimethoprim and erythromycin. Ciprofloxacin, Ofloxacin,   azetronam, 
cefotaxime, meropenem, gentamycin and ceftriaxone were the most active 
antimicrobial agents tested (Figure 4.17 and table 4.18). 
 
                                                           




Table (4.18): Susceptibility of Y. enterocolitica and A. hydrophila to various 
antimicrobial agents 
 
Clinical Isolates Environmental isolates 
Yersinia 
N= (14 ) 
Aeromonas 







S R % R S R % R S R % R S R % R 
Amikacin 14 0 0.0 87 16 15.5 13 1 7.1 60 16 21.1 
Ampicillin 5 9 64.3 0 103 100 10 4 28.5 0 76 100 
Amox/clav 0 14 100 0 103 100 1 13 92.9 0 76 100 
Aztreonam 13 1 7.1 95 8 7.8 13 1 7.1 64 12 15.8 
Cefazolin 0 14 100 0 103 100 0 14 100 0 76 100 
Cephalexine 4 10 71.4 0 103 100 4 10 71.4 0 76 100 
Cefotaxime 14 0 0.0 84 19 18.5 14 0 0.0 64 12 15.8 
Cefruxime 11 3 21.4 49 54 52.4 13 1 7.1 33 43 56.6 
Ceftazidime 12 2 14.3 53 50 48.5 9 5 35.7 37 39 51.3 
Ceftriaxone 13 1 7.1 65 38 36.9 13 1 7.1 54 22 28.9 
Ciprofloxacin 13 1 7.1 93 10 9.7 13 1 7.1 66 10 13.2 
Co-trimethoprim 14 0 0.0 0 103 100 8 6 42.8 0 76 100 
Chloramphenicol 10 4 28.6 25 78 75.7 11 3 21.4 23 53 69.7 
Doxycycline 8 6 42.9 22 81 78.6 8 6 42.8 30 46 60.5 
Erythromycin 0 14 100 0 103 100 0 14 100 0 76 100 
Gentamicin 14 0 0.0 86 17 16.5 13 1 7.1 56 20 26.3 
Meropenem 13 1 7.1 75 28 27.2 13 1 7.1 57 19 25 
Nalidixic acid 9 5 35.7 41 62 60.2 12 2 14.3 31 45 59.2 
Ofloxacin 13 1 7.1 92 11 10.7 13 1 7.1 65 11 14.5 
Tetracycline 8 6 42.9 22 81 78.6 7 7 50 29 47 61.8 
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The primary goals of the present study are to investigate the occurrence of Y. 
enterocolitica and A. hydrophila in clinical, food and environmental samples 
in Gaza strip, to recommend a simple and reliable procedure for the detection 
of pathogenic Y. enterocolitica and A. hydrophila and to use the procedure as 
a diagnostic tool for the rapid identification of Yersinia and Aeromonas 
cultures. In the present study; Y. enterocolitica was isolated from all types of 
samples except seawater while A. hydrophila was isolated from all sampling 
sources. 
 
5.1 Distribution of Yersinia enterocolitica and Aeromonas hydrophila 
 
Y. enterocolitica and A. hydrophila are detected in a wide range of samples 
such as fresh waters [13,33,109], vegetables [5,14], meats and milk products 
[32,121,138], fish [14], shellfish, seawater [5,168] and clinical [84,133]. In 
this study, a high percentage of Y. enterocolitica was recovered from sewage 
(19.1%) followed by animal excreta (11.5%) and higher percentage (48.9 and 
46.9%) of A. hydrophila isolates were identified in meat and water 
respectively.  
 
5.2 Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
clinical samples 
 
Of the 300 diarrheal stool samples tested, 14 (4.7%) were positive for Y. 
enterocolitica and 103 (34.3%) were positive for A. hydrophila. Y. 
enterocolitica and A. hydrophila were isolated either from stool samples from 
children or from older persons with diarrheal infections, with high incidence 
from patients below 6 years. Y. enterocolitica has been isolated from humans 
on all continents [24]. We found a frequency of 4.7% for this organism, which 
is lower than some parts of the world especially northern European countries 
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with a frequency up to 13% [5]. This might be partly due to the warmer 
climate in our country, wherein this study was carried out during summer. We 
would expect a higher frequency during autumn and winter, based on the fact 
that this organism increases greatly in comparison with other species in cold 
seasons [5]. 
 
In a comparable study in Montreal, Canada, specimens from children with 
gastroenteritis were tested during a 15-month period for pathogenic enteric 
bacteria. Y. enterocolitica was isolated from 2.8% of the human fecal 
specimens and 2.1% from the Oneida County outbreak [236]. 1.04% were 
isolated from 7,290 black Atlanta children during the Thanksgiving-Christmas 
holidays in 1988 [237].  
 
The differences between the findings of various authors and those of this 
study might be due to several factors such as; isolation methods, number of 
analyzed samples, sources of samples, season, and geographical location. 
These factors may cause an increase or decrease in the incidence of the 
Yersinia spp. For instance, the present study was carried out in Gaza strip, 
where the weather is generally warm and humidity is high. It is known that 
the isolation ratio of Y. enterocolitica is higher in colder climates. 
 
In case of A. hydrophila, our results were higher than the findings of 4.7 % 
incidence in Chennai, India, 2.8% in Los Angeles, California, hospital, 1.28 
%, and 1.4 % of A. hydrophila from Mumbai, India. Alavandi and Anandhan 
reported Aeromonas associated diarrhea in 1 to 13 % of samples in Chennai, 
while Kuijper et al., and Ogunsanya et al., reported 3.7 % in Netherlands 
and 1.4 % in Lagos, Nigeria respectively. However, higher prevalence of 17.7 
and 28.1 % were recorded during 2000 and 2001 in Kolkata, India. It is 
believed that gasteroenteritis caused by A. hydrophila occurs more 




Among 1,821 patients with diarrhea visiting a clinic in La Crosse, Wisconsin, 
during an 18-month period, Agger et al., identified 20 (1.1%) positive for A. 
hydrophila. Moyer examined 3,334 diarrheic stool specimens submitted by 
physicians over a 2-year period to an Iowa public health laboratory and found 
238 (7.1%) positive for A. caviae, A. hydrophila, or A. sobria. Isolation in the 
latter study included an alkaline peptone water enrichment step, which may 
explain the higher prevalence rate. Pazzaglia et al., reported that 23.1% of 
newborns in Peru demonstrated transitory gastrointestinal colonization with 
Aeromonas spp. during the first days of life [177]. 
 
Worldwide, the isolation rate of Aeromonas from diarrheic stool has been 
reported as high as 10.8% and as low as 0%. A study conducted in 
Southeast Asia, 34% A. hydrophila have been recovered from patients with 
diarrhea [177]. Another study among Western Peace Corp workers in 
Thailand, showed that  Aeromonas were recovered from 30.8% of persons 
with diarrhea which is similar to our results (34.3%) [177].  
 
This wide variation in the prevalence of Aeromonas among similar studies 
conducted on children with diarrhea may be attributed to the variation in fecal 
samples number and also to different methods used for isolation of 
Aeromonas as well as environmental condition, patient populations, food 
habits, and level of sanitation. 
 
5.3 Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
food samples 
 
In recent years, the number of studies on the prevalence of Y. enterocolitica 
and A. hydrophila in food products from various geographical regions has 
increased significantly [14,121].  In studies from different countries, Y. 
enterocolitica were isolated from various ready-to-eat products including, 
fresh salad, whole and sliced vegetables, sandwiches, milk, dairy products, 
desserts and soft cheese. In a study carried out in Finland, Fredriksson-
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Ahomaa et al.,  tested 200 samples of raw fish, 43 samples of raw chicken 
and 101 samples of lettuce by nested PCR targeting the yadA gene [6]. 
Three PCR-positive results were obtained, all recovered from the lettuce 
samples. Logue et al., investigated Irish meat and meat products and 
isolated pathogenic serotypes of Y. enterocolitica from 10% of samples of 
cooked ham (n=20), corned beef (n=40) and pork sausage (n=20). Wang, 
Cao and Cerniglia examined seafood and found that none of the samples 
tested positive for pathogenic Y. enterocolitica by PCR [125]. In an Australian 
study, Szabo, Scurrah and Burrows examined 120 samples of minimally 
processed lettuce collected over an 8-month period and isolated 71 Y. 
enterocolitica strains, all belonging to nonpathogenic serotypes [174].  
 
Raw and pasteurised milk have been examined in several studies because 
outbreaks over a number of years in the United States were traced to milk. 
Schiemann and Toma examined 131 raw milk samples for the presence of 
Y. enterocolitica. Forty-two isolations were obtained from 19 pooled- (31.1% 
positive) and 10 individual-producer samples (14.3% positive) [239]. The 
other study by Schiemann reported a high incidence of Y. enterocolitica in 
raw milk (18.2%), 9.2% in cheese curd samples and 0.4% in pasteurized fluid 
dairy products from southern Ontario [239]. 
 
Several studies have been conducted to isolate Yersinia spp. in ground beef 
and the isolation rate was reported to be 9-99.2%. Among these studies, 
some generated higher isolation rates than the results of this study. In the 
present study, Y. enterocolitica was isolated from 6.7% of meat samples. 
Inoue and Kurose and Leistner et al., found that Yersinia spp. were 
recovered from 24 and 16% of samples, respectively. Hanna et al., 
examined whole-sale cuts of vacuum-packaged fresh beef and reported that 
10 out of 107 beef samples (9.3%) were positive for Y. enterocolitica. 
Similarly, Ibrahim and MacRae examined 50 beef samples for Yersinia spp. 
and the isolation rate was 20%. 9 (18%) were Y. enterocolitica. Karib et al., 
also reported that 4 out of 30 beef meat (13.3%) and 3 out of 20 ground beef 
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samples (15%) were examined for Yersinia and Y. enterocolitica isolation 
rates were 13.3 and 15%, respectively. In another study by Falcao, 40 
cultures of isolated ground beef, 9 (22.5%) were Y. enterocolitica [106].  
 
Although the results of this study showed higher isolation ratio, the 
examination of a limited number of samples might have caused 
misinterpretation. It might also have been related to the efficiency of the 
detection method.  
 
In one study conducted in Norway, 47 samples of sausage meat and 99 
samples of pork chop collected from five slaughterhouses and one retail 
outlet were analyzed [125].The presence of pathogenic Y. enterocolitica was 
detected by PCR in 15% and 26% of these samples, respectively. In another 
study, Nesbakken et al., examined 12 samples of pork cuts and 33 samples 
of sausage meat and obtained 5 and 23 positives, respectively [88]. 
 
Ibrahim and MacRae  reported that Aeromonas was present in 60, 58, 74 
and 26% of investigated beef, lamb, pork and milk samples, respectively, 
whereas Krovacek et al., found aeromonads in 42% of the food samples 
originating from a random selection of retail outlets in Sweden. Aeromonas 
were also found in fish and fresh salads, freshly dressed lamb carcasses, 
oysters, cheese and raw cow's milk [14]. In the present study, Y. 
enterocolitica and A. hydrophila were isolated from 6%, 36% of the milk 
samples and 6.7%, 48.9% of meat samples respectively. Because of the 
obvious differences in sampling period, geographical location, the origin of 
the samples and methodology for analysis, it is difficult to compare the level 
of Y. enterocolitica and A. hydrophila incidence published by different 
authors. However, the present data clearly confirm the widespread 
distribution of Y. enterocolitica and A. hydrophila in retail foods.  
 
The recovery of pathogenic Y. enterocolitica and A. hydrophila is contingent 
upon a number of factors including the level of background flora on the 
sample, the amount of background flora coming from enrichment and plating, 
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the level of pathogenic Y. enterocolitica and A. hydrophila present in the 
sample, the numbers of non-pathogenic Y. enterocolitica and non-pathogenic 
Yersinia spp. present in the sample, and the loss of virulence factors during 
enrichment and plating. Furthermore, a difference in virulence factors may be 
to the different serotypes. Recovery method that gives good recovery of one 
particular serotype of pathogenic Y. enterocolitica may not suit another 
serotype. 
 
5.3  Recovery of Yersinia enterocolitica and Aeromonas hydrophila from 
environmental samples  
 
5.3.1 Water Samples 
 
Y. enterocolitica and A. hydrophila isolates recovered from different water 
samples, including chlorinated and non chlorinated, fresh water, well water, 
seawater, wastewater and natural mineral water. Most of these 
microorganisms were found to be nonpathogenic [5,13,33].  
 
The possibility for these microorganisms to survive in this type of 
environment has been investigated. Chao, Ding and Chen showed that Y. 
enterocolitica could survive in soil and water systems, especially at low 
environmental temperatures [125]. Karapinar and Gonul found that a mixed 
culture of nonpathogenic and pathogenic strains held at 4ºC was recovered 
after 56 weeks incubation in sterile spring water. In our study, water isolates 
represented two (6.3%) of a total of 32 water samples which is lower than 
those reported in other parts of the world. Shayegani et al., isolated 147 Y. 
enterocolitica and related species from 622 water samples; 23 (15.6%) were 
Y. enterocolitica. Some researchers reported that even lower isolation ratios 
were detected compared to the results of this study [236]. In a study carried 
out in Australia, Sandery, Stinear and Kaucner tested 251 water samples 
by nested PCR. Eleven samples (4.4%) from 4 separate locations tested 
positive [125].  
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In this study, A. hydrophila was isolated (46.9%) from different water 
samples. A. hydrophila is also associated with the aquatic environment and 
has been isolated from tap water, well water, seawater and wastewater; 
sometimes at quite high levels [134,151]. Knochel and Jeppesen examined 
drinking-water in Denmark and found that only 28% of samples were positive; 
A. hydrophila made up 97% of isolates. In contrast, Ghanem, Mussa and 
Eraki reported that 90% of domestic water supplies in areas of Cairo 
contained Aeromonas, while from a survey of three distribution systems in 
Sweden, Krovacek et al., reported that 85% of samples were positive for 
presumptive Aeromonas; A. hydrophila accounted for 67% of the strains 
isolated. Stelzer et al., recorded a maximum count of 240 Aeromonas/100 ml 
in a drinking-water supply in Germany, with an isolation frequency for A. 
hydrophila of 37%. The highest counts were obtained from points furthest 
(>10km) from the treatment works. Havelaar, Versteegh and During 
reported regrowth of aeromonads in 16 of 20 distribution systems examined 
in the Netherlands [150].  
 
Legnani et al., reported occurrence of Aeromonas spp. in drinking water 
supplies in a mountain area in northeast Italy (the Dolomites). Out of 7395 
water samples analyzed over a 3 years period, 1623 (21.9%) were found to 
be positive for Aeromonas; 72.4% of the strains were identified as A. 
hydrophila [240]. Ghenghesh et al., isolated Aeromonas in 48.7% of 1,000 
water samples obtained from wells and other miscellaneous sources. A. 
hydrophila were detected in 59% of samples tested [222]. Ormen et al., 
investigated the occurrence of Aeromonas spp.  in Norwegian natural water 
sources. 42% of the total isolates were identified A. hydrophila [241]. 
 
5.3.2 Sewage samples 
 
In our study 5 Yersinia spp. were recovered from 26 sewage samples. Y. 
enterocolitica was found in 3(12%) whereas Y. kristensenii in 2 (8%). On the 
other hand; 11 A. hydrophila (42%) were recovered from the same samples. 
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Most of the Y. enterocolitica isolates recovered from environmental samples, 
including fodder, soil, foliage, surface water, sewage water and sludge, have 
been non-pathogenic. Singh et al., reported isolation of Y. enterocolitica 
from sewage effluents collected from several sewage treatment plant in Delhi 
city (India), 9 (12.3%) from wastewater, 5 (2.8%) from groundwater and 4 
(9%) from river Yamuna [242], similar to the result of this study. In another 
study Yersinia spp. were detected in 90.6% out of 32 raw wastewater 
samples obtained within one year from two municipal sewage treatment 
plants. Moreover, Yersinia was isolated from 50% of 6 effluent samples. The 
remaining isolates were identified as Y. frederiksenii (24 isolates), Y. 
intermedia (22 isolates) and Y. kristensenii (3 isolates) [243].  
 
Aeromonas are widespread in wastewater treatment processes. Burke et al., 
isolated 34% of Aeromonas spp. from the unchlorinated domestic water 
supply of a country center in Western Australia [244] yielding lower result 
than our study. The persistence and transmission of Aeromonas in a 
duckweed aquaculture-based hospital sewage water treatment plant in 
Bangladesh was studied. A total of 670 samples from different sites of the 
hospital sewage water treatment plant, from feces of hospitalized children 
suffering from diarrhea, from environmental control ponds, and from feces of 
healthy humans were collected over a period of three years. All samples (n = 
86) from the sewage water treatment plant but only 27 out of the 68 (40%) 
samples from the control ponds were positive for Aeromonas similar to this 
study. The highest mean number of Aeromonas bacteria was found in 
untreated sewage samples [245]. 
 
5.3.3 Animal excreta samples 
 
Animals, especially domestic animals, have been suspected as transmitters 
of Y. enterocolitica and A. hydrophila to humans [5,188,189]. Published 
studies are contradictory in this regard. The Member States of the Europeans 
report annually to the EU-Commission on the Zoonoses situation in their 
country. However, Y. enterocolitica infection in animals is not notifiable, and 
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reports on its prevalence are for the most part results from research projects 
obtained from institutions or authorities in the member countries. Various 
studies have investigated wild and farm animals for the presence of 
pathogenic strains of Y. enterocolitica. Shayegani et al., examined fecal 
specimens from 1,426 animals including mammals, birds, reptiles, fish and 
invertebrates throughout New York State. Strains of Y. enterocolitica and 
related species were isolated from 92 (11.3%) of 812 mammals, 36 (6.3%) of 
573 birds and 5 (17.8%) of 28 reptiles and fish [236]. 
 
In various studies examining healthy domestic animals and animals with 
acute enteritis, including cattle, sheep, goats, deer, calves, broilers, hens, 
turkeys and ducks, only a few pathogenic isolates have been recovered, and 
they differed from those usually associated with human infections. Virulent Y. 
enterocolitica was isolated from one or more sheep in 78 (17%) of 449 flocks 
[101].  These results are in agreement with our results, where we found that 
11.5% of our studied animal excreta were positive to Y. enterocolitica. 
 
In a German study, Gurtler et al., found that the prevalence of Y. 
enterocolitica ranged between 0 and 65% in fattening pig herds and was 
present in 39% of pig tonsils at the abattoir. In Denmark and Norway, the 
frequency of Y. enterocolitica O:3 at herd level has been found to be 64% 
and 70% respectively. Korte et al., found that the prevalence in fattening 
pigs in Finland, investigated in five slaughterhouses, increased from 33% to 
64% between 1995 and 1999. In a study performed in Sweden between 1997 
and 1998, the frequency at herd level was 67% [125]. These results are 
higher than our results and may be due to the fact that raw pork was main 
reservoir of Y. enterocolitica and transmitted to the other animals. 
 
On the other hand, Aeromonas spp. have been recognized as animal 
pathogens since they were first isolated from diseased frogs and fish. They 
are now recognized to cause disease in birds and domestic animals [189]. 
Gray isolated A. hydrophila from feces of normal horses (7 of 110, 6.4%), 
pigs (11 of 115, 9.6%), sheep (10 of 111, 9.0%), and cows (26 of 123, 
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21.1%). The total fecal carriage rate in animals is slightly higher than the 
fecal carriage rate of normal humans, which is < 1 to 7% for most studies, 
although some studies report higher rates [245]. Populations in animals 
probably reflect the presence of aeromonads in their feed and water.  
 
In the present study Y. enterocolitica was isolated from 11.5% of the total 
animal excreta samples. (14.3% of turkeys, and 28.6% of cows) and A. 
hydrophila was recovered from 38.5% of the total samples (28.6% of turkeys, 
42.9% of cows and 62.5% of goats) but none were isolated from chicken in 
this study. Other studies reported that even lower isolation rates were 
detected compared to the results of this study. Stern et al., isolated 
aeromonads from 1 (3.1%) of 32 cows and 3 (14.2%) of 21 turkeys, but none 
were isolated from 22 pigs or 24 sheep [150].  
 
In our study, isolates of Y. enterocolitica and A. hydrophila were found in 
human, animal and environmental sources. This suggests the possibility of 
transmission from environment or animals to humans. 
 
5.6 Isolation of Yersinia enterocolitica and Aeromonas hydrophila using 
different enteric agar media 
 
SS, HE, XLD, MCAand CIN were used to selectively isolate Y. enterocolitica 
and A. hydrophila. 
 
5.6.1 Evaluation of the efficacy of selective media for the recovery of 
Yersinia enterocolitica and Aeromonas hydrophila from clinical and 
food samples 
 
The number of proven bacterial gastroenteritis agents has increased over the 
past several years and now includes such diverse groups as certain 
serotypes of Yersinia enterocolitica, Campylobacter spp., invasive 
Escherichia coli (O:157, H:7), Plesiomonas shigelloides, new halophilic Vibrio 
spp., and Aeromonas spp. Because the development of enteric agars, 
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essentially designed for the primary isolation of Salmonella and Shigella spp., 
predated the discovery of these bacteria, either new selective agars are 
required to isolate these microorganisms (as in the case of Campylobacter 
spp.) or laboratory workers must make use of existing selective and 
differential agars [232].  
 
From this study, it is apparent that routine media used in our laboratory are 
unsatisfactory for the recovery of Y. enterocolitica and A. hydrophila, owing to 
the poor plating efficiency and  recovery of these organism from stool 
specimens are difficult because not only are Y. enterocolitica and A. 
hydrophila indistinguishable from many other enteric organisms which do not 
ferment lactose on MCA or SS agar, but it may also be easily overgrown by 
most intestinal bacterial flora since the former grows relatively slowly. 
Additionally, Y. enterocolitica and A. hydrophila are capable of growth on 
XLD or H-E agar and ferment the sucrose and xylose in the former medium 
and salicin and sucrose in the latter, thereby rendering colonies 
indistinguishable from "coliforms".  
 
The CIN agar used in this study provided the most effective medium for the 
recovery of Y. enterocolitica and A. hydrophila. The confirmation rate of 
identification of presumptive Y. enterocolitica and A. hydrophila from CIN was 
100% but the isolation rate of Y. enterocolitica and A. hydrophila was 7.1% 
and 2.9% on HE and XLD agar and 8.1% and 3.9% on SS agar respectively. 
The greatest advantage of CIN agar is that Y. enterocolitica and A. 
hydrophila with red colonies on CIN agar are easily differentiated from most 
other gram-negative bacteria, which showed pink or dark-red colonies or 
transparent colonies with a peripheral dark zone as the result of mannitol 
fermentation and CIN agar dramatically inhibits normal flora organisms. 
 
Head et al., conducted comparative studies of several selective media 
including MacConkey agar for the recovery of Y. enterocolitica. They found 
that CIN agar was the most effective, yielding 100% recovery of Y. 
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enterocolitica in a test suspension containing 10 CFU/ml. Using a 
combination of CIN agar and cold enrichment during a 42-month period, 
these investigators isolated 80 Y. enterocolitica and 52 Y. enterocolitica-like 
strains (42 Y. frederiksenii, 8 Y. intermedia, and 2 Y. kristensenii) from 215 
fecal specimens from 171 patients [24].  
 
Many investigators [85,226,229] reported that CIN agar was a more effective 
agar medium than SS and MCA agars for the isolation of Y. enterocolitica 
and A. hydrophila from various specimens. Schiemann reported that a color 
reaction resulting from the fermentation of mannitol presents a characteristic 
colony appearance which can serve to differentiate Y. enterocolitica and A. 
hydrophila from most other gram negative bacteria able to grow on CIN agar 
with added mannitol and differentiate Y. enterocolitica from A. hydrophila by 
oxidase test [78]. These findings suggest that CIN agar is a useful medium 
not only for isolation of Y. enterocolitica but also A. hydrophila.  
 
5.6.2 Efficacy of KOH treatment 
 
In our study the highest isolation rates of Y. enterocolitica and A. hydrophila 
were obtained after KOH treatment. All Yersinia and Aeromonas isolates 
were detected in large numbers on CIN agar on primary isolation, after 
treated with KOH. No additional isolates were detected following cold 
enrichment and following overnight enrichment in TSB. The percent recovery 
of Yersinia and Aeromonas by the KOH method was 100% as compared with 
78.6% recovery for Y. enterocolitica and 76.7% for A. hydrophila after 14 
days of incubation at 4oC. We obtained a 100% recovery for Y. enterocolitica 
and a 94.2% for A. hydrophila by Trypticase soy broth after 48 h incubation. 
 
Recovery of Yersinia and Aeromonas from environmental samples are 
complicated by a technical difficulty rather than by a nutritional requirement of 
Yersinia and Aeromonas. Because Yersinia and Aeromonas grows more 
slowly than non- Yersinia and Aeromonas organisms, their population is 
quickly overgrown and easily masked when streaked on a weakly selective 
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isolatory agar. By treating the inoculum with 0.5% KOH in 0.5% NaCl, the 
difficulty is largely overcome. The alkali treatment killed or inhibited a larger 
number of contaminating non- Yersinia and Aeromonas and thus facilitated 
the isolation of Yersinia and Aeromonas [78,79].  
 
The alkali method provides a simple, sensitive, and rapid technique for the 
recovery of Y. enterocolitica and A. hydrophila from mixed cultures, 
especially from food samples. A report has appeared describing the benefit 
of alkali treatment for recovery of Y. enterocolitica and A. hydrophila from 
feces [78]. These finding determined the usefulness of dilute alkali (KOH) 
treatment of meat samples for direct isolation of Y. enterocolitica and A. 
hydrophila without enrichment shortened the incubation period and 
appreciably decreased the growth of non-Yersinia and Aeromonas isolates 
from clinical and food samples. 
 
5.7 Virulence factors of Yersinia enterocolitica and Aeromonas 
hydrophila  
 
Virulence factors were compared for 14 Y. enterocolitica and 103 A. 
hydrophila isolated from clinical samples with 16 Yersinia spp. and 76 A. 
hydrophila isolated from environmental samples in the same area during the 
same period. Yersinia and Aeromonas spp. isolated from clinical samples 
showed differences in virulence characteristics when compared with strains 
isolated from environmental samples in the same environment [95,127]. 
 
Isolates of Y. enterocolitica and A. hydrophila had several properties shown 
to be virulence-associated by other workers. Pathogenic Y. enterocolitica 
isolates autoagglutinated at 35°C, positive for crystal violet binding and 
negative for esculin hydrolysis and pyrazinamidase activity. On the other 
hand, pathogenic A. hydrophila isolates were positive for autoagglutination, 




A.  Pyrazinamidase test 
 
 The pyrizinamidase test was easy to perform. The pyrazinamidase test 
correctly identified 94% Yersinia isolates [10]. Our results showed that both 
clinical and environmental isolates were positive for virulence test markers, 
with high percent in clinical isolates. 64.3% of clinical isolates were negative 
compared to only 33.3% of environmental isolates. This was in disagreement 
with the results of several authors. 
 
 Kandolo and Wau-ters investigated pyrazinamidase in 381 strains of Y. 
enterocolitica isolated from human, animal and environment sources from 
different geographical areas. They showed that pyrazinamidase test was 
negative (PYZ-) in all bioserogroups of Y. enterocolitica, in which is usually 
harbored the virulence plasmid, and was involved in human or animal 
diseases. The more ubiquitous bioserogroups of Y. enterocolitica, without 
naturally occurring virulence plasmid, and related species were all Pyz+. 
They found 100% accuracy in differentiating pathogenic and nonpathogenic 
serotypes. All Y. kristensenii isolates were positive for Pyrazinamidase 
activity similar to the results of the present study [246].  Siriken reported that 
none of the Y. enterocolitica isolates recovered from ground beef was 
positive for virulence assays [106]. 
 
Our results were disagreement with other studies; 33.3% of Y. enterocolitica 
were virulent. Vishnubhatla et al., reported that Y. enterocolitica was virulent 
in 30 (60%) of 50 ground beef samples [106]. Riley and Toma noted that 5 
of their 21 strains of Y. enterocolitica serotype O:1,2,3 were pyrazinamidase 
positive, indicating a nonpathogenic serotype; lower than our results [92].  
 
Carnahan et al., investigated pyrazinamidase activity of Aeromonas spp.  Of 
the 37 A. hydrophila isolates tested, 35 (95%) were positive, which is similar 
to our result where we found that 92.2% of clinical isolates were positive for 
pyrazinamidase and 30.2% of environmental isolates were negative [191]. 
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B.  Esculin hydrolysis 
 
In our study a total of 35.7%, 92.2% of clinical Y. enterocolitica and A. 
hydrophila isolates were positive for bile esculin hydrolysis respectively. 
While, 64.3%, 60.5% of environmental Y. enterocolitica and A. hydrophila 
isolates were positive respectively. Farmer et al., reported esculin hydrolysis 
of Y. enterocolitica. A negative reaction of esculin hydrolysis correctly 
identified all 63 strains of the pathogenic serotypes (100% sensitivity), and a 
positive results correctly identified 34 of 37 strains of nonpathogenic 
serotypes (92% specificity). Thus, esculin hydrolysis correctly identified 97% 
of the isolates [10].  
 
Carnahan et al., investigated esculin hydrolysis of Aeromonas spp. Of the 
167 clinical Aeromonas spp., isolates tested, 114 (68%) were positive. Most 
of A. hydrophila isolates were positive agreement with our result, (92.2%) 
Aeromonas clinical isolates were positive [129]. It can be concluded that 
esculin hydrolysis agar, available in most clinical laboratories for the 
identification of Enterococcus spp., can be used for differentiation of 




Farmer et al., reported that only 8 (12.7%) of 63 Yersinia strains were 
positive for autoagglutination in MR-VP broth [10]. Laird and Cavanaugh 
pointed out that 25 (13.8%) of 180 Y. enterocolitica strains were found to be 
agglutinated [247]. These results disagree with our findings where 64.3% of 
clinical isolates were positive and only 35.7% of environmental isolates were 
positive. Janda et al., described a group of Aeromonas strains; of 79 
mesophilic aeromonads (13 environmental and 66 clinical isolates) evaluated 
for the ability to autoagglutinate in BHIB before (AA+) or after boiling (PAB+), 
24 (30%) were positive (AA+). Among A. hydrophila, 6 (55%) of 11 from 
invasive disease were AA+, and 8 (28%) of 29 from noninvasive disease 
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were AA+ [164]. These results are lower than our result, 92.2%, 36.8% were 
positive for clinical and environmental isolates respectively. 
 
D. Crystal violet binding 
 
CV binding was also tested by Farmer et al., with mixed cultures of the 
Plasmid-bearing virulent strains of Y. enterocolitica (P+) and avirulent 
plasmidless derivatives (P-) strains. Average percent binding was 94% [10]. 
Our results showed that 64.3%, 92.2% of clinical Yersinia and Aeromonas 
isolates were able to bind crystal violet dye and 35.7%, 36.8% of 
environmental Yersinia and Aeromonas isolates were positive respectively. 
Paniagua et al. reported that 44 (49.5%) from 74 A. hydrophila isolated from 
rainbow trout fish were able to bind crystal violet dye [234]. 
 
Differences in virulence marker activities, possibly due to differences 
observed between strains isolated from different geographic locations and 
between different species and the loss of virulence factors during enrichment 
and plating. 
 
E. β- hemolysin production 
 
The results of this study showed that 93% of A. hydrophila were hemolysin 
producer and this is in agreement with previous reports. Subashkumar et 
al., reported that from 21 isolates of A. hydrophila tested 20 (95.2%) of them 
were hemolysin producers. The isolates varied in their ability to lyse the red 
blood cells of human origin. Overall 90.47, 4.76 and 4.76% isolates were 
beta, alpha and gamma hemolytic, respectively. Attention has been given on 
the hemolysin of motile A. hydrophila because the production of hemolytic 
toxin has been regarded as indication of pathogenic potential, though 




As defined by Wong et al., all A. hydrophila isolates with haemolysin positive 
genotype were virulent in the suckling mouse assay model. Burke et al., 
reported 97% correlation between hemolysin and enterotoxin production 
determined by suckling mouse test. It was found that all enterotoxigenic A. 
hydrophila isolates produced hemolysins [238].  
 
Sixty-eight (91.89%) A. hydrophila strains were hemolytic, as shown on blood 
agar reported by Paniagua et al., [234]. Mateos et al., showed that A. 
hydrophila isolates from the environment were avirulent for mice, whereas 
human isolates caused lesions and death in these laboratory animals [149]. 
 
5.8 Susceptibility of Yersinia enterocolitica and Aeromonas hydrophila 
to various antimicrobial agents 
 
Yersinia enterocolitica and Aeromonas hydrophila have emerged as an 
enteropathogen associated with several types of human infections that often 
require antimicrobial therapy, but little is known about the antimicrobial 
susceptibilities of these pathogenes in Gaza strip. 
 
In this study, total of 117 clinical isolates of Y. enterocolitica (14) and A. 
hydrophila (103) and a total of 90 environmental isolates (14 of Y. 
enterocolitica  and 76 A. hydrophila) were tested for their susceptibility to 
antibiotics. All isolates were tested by a standard disk diffusion method for 20 
antibiotics. The present study demonstrated a high susceptibility of clinical 
strains of Y. enterocolitica to most of the tested antibiotics. No major 
difference in susceptibility was observed between any of the isolates of 
human or environmental isolates included in this study. 
 
These results are in agreement with those of previous investigations; 
Rastawicki et al., demonstrated that almost all strains tested were resistant 
to ampicillin and cefazolin and susceptible to amoxycillin/clavulanate, 
cefaclor, cefamandole, cefuroxime, cefotaxime, ceftriaxone, aztreonam, 
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imipenem, gentamicin, amikacin, netilmicin, tetracycline, doxycycline, 
chloramphenicol, ciprofloxacin, sulphamethoxazole, trimethoprim, co-
trimoxazole and furazolidone. The only disagreement was with 
amoxicillin/clavulanate [ 248].  
 
Preton et al., showed that all strains tested were susceptible to ciprofloxacin 
and piperacillin, and 98% of the strains were susceptible to trimethoprim, 
sulfamethoxazole, cotrimoxazole, tetracycline, chloramphenicol, 
cefamandole, cefotaxime, aztreonam, and four aminoglycosides. In contrast, 
all strains were nonsusceptible to erythromycin, furazolidone, and 
clindamycin and 90% of the strains were non-susceptible to ampicillin, 
carbenicillin, ticarcillin, and cephalothin [249]. In agreement with our findings, 
Kwaga and Iversen reported that Yersinia isolated from slaughtered pigs 
and pork products in Canada in 1990 displayed little or no resistance to the 
aminoglycosides, cephalosporins (cefotaxime, ceftazidime, and ceftriaxone), 
imipenem, ticarcillin-clavulanic acid, aztreonam, ciprofloxacin, norfloxacin, 
trimethoprim-sulfamethoxazole, chloramphenicol, tetracycline, and co-
trimoxazole [249]. 
 
Our data showed that pathogenic Y. enterocolitica isolates were susceptible 
to co-trimoxazole, amikacin, gentamycin, ciprofloxacin and meropenem, they 
also indicate that the agents used traditionally to treat human infections, 
including co-trimoxazole, tetracycline, chloramphenicol, and the third 
generation cephalosporins, retained their high levels of in vitro activities. 
However, our results do not rule out the potential for this species, like other 
members of the family Enterobacteriaceae, to acquire decreased 
susceptibility to multiple antimicrobial agents and emphasize the need for 
continued surveillance of the susceptibility patterns of Y. enterocolitica and A. 
hydrophila from both human and animal sources.  
 
The spread of drug resistance among Aeromonas spp., is of concern 
because recent surveys indicate the emergence of these organisms as 
primary human pathogens. The presence of antibiotic resistant A. hydrophila 
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in natural habitats can pose a public health risk. Occurrence of multiple 
antibiotic resistant A. hydrophila in shoreline sediments, marine waters and 
shellfishes has been recognized as an important public health hazard. The 
prevalence of such multiple antibiotic resistant organisms in food and water is 
of considerable significance in relation to public health. Multiple antibiotic 
resistance of A. hydrophila strains from organs of infected catfish, Clarius 
batrachus has been reported [127,218 ].  
 
In this study, the frequency of resistance to some antimicrobial agents was 
much greater than previously reported. In other studies, frequency of 
resistance was exhibited against ampicillin followed by streptomycin, 
chloromphenicol and nalidixic acid. But all isolates exhibited susceptibility to 
tetracycline. Strains of Aeromonas spp. also showed high frequency of 
resistance to vancomycin, novobiocin, rifampicin and methicillin. Son Radu 
et al., have reported resistance towards chloromphenicol, erythromycin, 
kanamycin, nalidixic acid, streptomycin, sulphamethoxazole - trimethoprim 
and tetracycline among A. hydrophila isolates from cultured fish. Pettibone 
et al., reported the susceptibility of Aeromonas spp. to chloromphenicol, 
erythromycin, kanamycin, polymyxin-B, streptomycin and trimethoprim. 
These antibiotics are generally active agents against strains of Aeromonas 
[250].  
 
Jones and Wilcox showed that aztreonam and the carbapenems, imipenem 
and meropenem remain highly active. Although resistance to the first and 
second generation cephalosporins is variable, more than 90% of Aeromonas 
spp. are susceptible to the third generation agents. While most strains are 
susceptible to chloramphenicol, ciprofloxacin, co-trimoxazole and the 
aminoglycosides, the activity of amoxycillin/clavulanate and the 




Imipenem and meropenem are also extremely active against all Aeromonas 
spp. Meropenem is generally more active than imipenem. More than 90% of 
Aeromonas spp. are susceptible to the third generation cephalosporins, such 
as cefotaxime, cefoperazone, cefpirome and ceftazidime. The activity of the 
first and second generation cephalosporins differs more widely between the 
three clinically important species of Aeromonas [218]. 
 
Subashkumar et al., reported that A. hydrophila isolates from children with 
acute diarrhea exhibited resistance to bacitracin (95.2%), novobiocin 
(95.2%), vancomycin (90.5%), methicillin (85.7%), cefazoline (85.7%), 
kanamycin (81%), rifampicin (76.2%), erythromycin and tetracycline (71.4% 
each) and nalidixic acid (62%). All the isolates were resistant to ampicillin as 
has been reported earlier [251]. The isolates exhibited susceptibility to 
polymyxin B (95.3%), chloramphenicol (90.5%) and gentamicin (76.2%). 
Earlier studies revealed the incidence of chloramphenicol resistance strains 
[238].  
 
Most of the isolates were from the high risk source contamination like fecal-
oral contamination. Due to indiscriminate use of antibiotics; the 
microorganisms might have developed resistance towards several antibiotics. 
Differences in resistance patterns were observed between strains isolated 
from different geographic locations and between different species. 
 
Antibiotic resistance in Aeromonas spp. poses a potential problem in the 
antimicrobial therapy of infections caused by these organisms. From our 
results, it is wise to avoid the use of broad-spectrum ampicillins, 
amoxycillin/clavulanate, co-trimethoprim, first and second generation of 
cephalosporins as first choice agents, particularly for invasive infections. 
Fluoroquinolones such as ciprofloxacin and Intravenous cefotaxime and 
meropenem are recommended for the treatment of serious Aeromonas 










To our knowledge, this is the first study that investigated the occurrence of Y. 




1. The results of this study confirmed the presence of pathogenic Y. 
enterocolitica and A. hydrophila in clinical, food and environmental samples. 
 
2. Conventional microbiological techniques used in the present study were 
shown to be an efficient tool for isolating and identifying both Y. enterocolitica 
and A. hydrophila isolates. 
 
3. The percentages of Y. enterocolitica and A. hydrophila in clinical samples 
(diarrheal stool) were 4.7% and 34.3% respectively with no isolates from 
appendiceal samples collected from 8 hospitals located in various parts of 
Gaza strip and examined with enrichment and selective culture procedures. 
Other enteropathogenes, Salmonella (1%) and Shigella (1%) were recovered 
from the same samples. 
 
4. The age group 2-6 years was shown to have the highest incidence rates of 
Y. enterocolitica and A. hydrophila infection.  
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5. Al-Dorrah hospital showed the highest incidence rate of Y. enterocolitica 
(21.4%) while Al-Nasser hospital showed the highest incidence of A. 
hydrophila (44.6%). 
 
6. The results showed the presence of Y. enterocolitica and A. hydrophila in 
milk samples with high level of Y. enterocolitica (16.7%) in cow's milk, and 
66.7% of A. hydrophila in goat's milk. 
 
7. From meat samples we obtained an average of 6.7% of Y. enterocolitica 
and 48.9% of A. hydrophila with high incidence of Yersinia in turkey's and 
cow's meat samples and high incidence of Aeromonas in most meat 
samples. 
 
8. Y. enterocolitica and A. hydrophila were isolated from 32 various water 
samples. The isolation rate was 6.25% for Y. enterocolitica and 46.9% for A. 
hydrophila with the highest incidence in tap and well water. 
 
9. Y. enterocolitica and A. hydrophila were also found in sewage samples 
with isolation rate 12% of Y. enterocolitica and 42% of A. hydrophila. The 
high isolation rate was in Al-Nasser hospital. Other two environmental 
Yersinia species, Yersinia kristensenii (7.7%) were recovered from the same 
samples. 
 
10. Y. enterocolitica (11.5%) and A. hydrophila (38.5%) were also detected in 
animal excreta samples from different animals in Gaza strip. The highest 
occurrence of Y. enterocolitica was in cow's excreta, while goat's excreta 
showed the highest incidence of A. hydrophila. 
 
11. The CIN agar used in this study provided the most effective medium for 
the recovery of Y. enterocolitica and A. hydrophila from clinical and food 
samples. The confirmation rate of identification of presumptive Y. 
enterocolitica and A. hydrophila from CIN was 100%.  
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12. This study showed that direct plating on CIN agar after treatment with 
KOH treatment was more efficient than the widely accepted method of cold 
enrichment in PBS and overnight enrichment in TSB for the detection of Y. 
enterocolitica and A. hydrophila from clinical and food samples. 
 
13. KOH method has the following advantages: (i) it uses a single enrichment 
medium, (ii) it eliminates 1 day of enrichment and another for the 
presumptive isolation, and (iii) it uses a single medium (CIN) for direct 
detection and isolation. This procedure is a practical alternative to many 
other recovery methods (PBS, TSB) which require significantly more time for 
completion, reducing the time required for detection up to 72 h by TSB and 
up to three weeks by PBS. 
 
14. Virulence factors were detected among clinical isolates as well as among 
isolates from other sources with higher frequency in clinical isolates. 
 
15. Y. enterocolitica retained its susceptibility to antimicrobials traditionally 
used treat human infections, including cotrimoxazole, tetracycline, 
chloramphenicol, and the aminoglycosides (amikacin, gentamicin). 
 
16. High incidence of multiple drug resistant and β- hemolysin producing A. 














In light of the result of this study and the above listed conclusions, the 
following actions are recommended. 
 
• Further epidemiological studies are necessary to elucidate the public health 
significance of infections caused by Y. enterocolitica and A. hydrophila. 
 
• The results of the present investigation suggest that further epidemiological 
studies are necessary to elucidate the public health significance of Yersinia 
and Aeromonas in food and water samples. 
 
• Further studies are also needed to determine contamination routes and 
transmission pathways of Yersinia and Aeromonas.  
 
• Further studies are needed to assess the clinical significance of the 
virulence factors in both food and water isolates. 
 
• More studies should be performed to indicate the relative importance of Y. 
enterocolitica and A. hydrophila in acute diarrhea in Gaza strip in both 
humans and animals. 
 
• Further careful epidemiologic studies are needed to determine the impact 
of restriction of antimicrobial use in limiting the spread of multi-drug 
resistance Aeromonas. 
 
• Y. enterocolitica and A. hydrophila isolation and identification services 
should be offered by the Ministry of Health Laboratories (Both medical and 
food microbiology laboratories). 
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• We thus recommend the direct plating on CIN agar after KOH treatment 
method for routine Yersinia and Aeromonas screening and propose that this 
method could be used to detect the occurrence of Yersinia and Aeromonas in 
clinical and environmental samples.  
 
• This study indicates that the rate of Y. enterocolitica and A. hydrophila is 
high in cow's meat and cow's excreta. This may suggests that the Monitoring 
Authorities to take serious procedures in order to protect consumers from the 
presence of Y. enterocolitica and A. hydrophila. 
 
The author would like to recommend the establishment of a local culture 
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